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University of Pittsburgh, 2015 
 
Toxoplasma gondii is an obligate intracellular protozoan parasite that is estimated to infect a third 
of the human population. While parasite infection is usually asymptomatic in healthy individuals, 
it is responsible for life threatening disease in individuals with compromised immune systems. The 
obligate intracellular nature of the parasite makes its ability to successfully invade and interact 
with its host cell of paramount importance. How T. gondii interacts with its host cell to permit its 
survival and replication is still largely understood. Our knowledge of host-pathogen interaction 
would be strengthened if a system were available to specifically label parasite proteins in the 
context of an infected host cell. My thesis work in the Boyle laboratory has focused on developing 
such a system in T. gondii. 
 I have created a strain of T. gondii that expresses a mutant form of a bacterial methionyl-
tRNA synthetase (MetRSNLL), which permits methionine (Met) tRNA to be charged with the azide-
containing Met analog, azidonorleucine (Anl).  Any protein that incorporates Anl is susceptible to 
a copper-catalyzed “click” reaction, allowing affinity tags for purification or fluorescent tags for 
visualization to be appended to them. I show that Anl is only incorporated into parasites expressing 
the mutant MetRSNLL, and that it is absent from host cell proteins. While the approach allows for 
the labeling of a large margin of parasite proteins, it appears that N-terminally processed proteins 
are only minimally labeled. This may be due to the bacterial MetRSNLL only being able to charge 
Anl to the T. gondii initiator tRNAMet and not the elongator tRNAMet, which would result in only 
the N-terminal Met residue being replaced with Anl. I have begun work to try to modify the system 
to permit Anl to be more widely incorporated into parasite proteins. Despite the systems current 
limitations, it should be useful for studying proteomic changes in the parasite while inside of the 
host. Furthermore, the system should be readily adaptable for other Apicomplexan parasites, like 
Plasmodium spp. 
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1.0 INTRODUCTION 
Toxoplasma gondii is the obligate intracellular protozoan parasite responsible for the 
disease toxoplasmosis in humans. It is a member of the phylum Apicomplexa, which includes 
important human pathogens aside from T. gondii. Plasmodium spp. is one of the most noteworthy 
examples, being the causative agent of malaria. In 2012, Plasmodium spp. were estimated to be 
responsible for over 600,000 deaths, the vast majority being children in Africa 1. While T. gondii 
infection is not responsible for as many deaths in humans, it has been estimated that close to a 
third of the human population is infected with T. gondii, with infection rates as high as 70% in 
some geographic regions 2.  Infection in humans is generally asymptomatic in individuals with 
healthy immune systems, though it can cause severe encephalitis in patients with human 
immunodeficiency virus (HIV)/acquired immunodeficiency syndrome or individuals taking 
immunosuppressive drugs for organ transplants. Also, if a woman first becomes infected with T. 
gondii during pregnancy, it can lead to hearing loss, blindness, and even death in the developing 
fetus 3,4. 
1.1 HOST RANGE 
T. gondii not only infects humans, it is able to infect virtually all warm-blooded animals. 
The genus Toxoplasma only has a single species (gondii), which is able to infect all the 
aforementioned organisms. This is unique compared other apicomplexans, which have much more 
restricted host ranges 5. The Plasmodium genus has over 200 species which differ in the vertebrate 
hosts that they can infect. All Plasmodium species have an obligate two host life cycle, alternating 
between a mosquito vector and a vertebrate host. Malaria affects a wide range of vertebrates other 
than humans, including reptiles, birds, rodents, and non-human primates, though there are different 
Plasmodium species for each of these vertebrate hosts 6. The reasons for the disparity in host ranges 
between T. gondii and other apicomplexans is currently unknown 5,7. 
1.2 LIFE CYCLE 
Like most apicomplexans, T. gondii has a complex life cycle with both asexual and sexual 
stages 8. It can reproduce asexually in all warm-blooded animals (the intermediate host), but is 
known to sexually reproduce in the intestines of felines, including domestic cats and larger wild 
cats like lions and tigers (the Felidae family; the definitive host). 
1 
 
1.2.1 Asexual reproduction 
The asexual phase of the parasite’s life is divided into two distinct stages (Fig. 1). Acute 
infection is characterized by a quickly growing form of the parasite known as the tachyzoite. 
Tachyzoites replicate within host cells inside a vacuole composed mainly of the host cell plasma 
membrane, dividing every 6 to 8 hours until the infected host cell lyses due to parasite buildup 9. 
The released parasites then go on to infect neighboring cells 10. The tachyzoite stage is the most 
experimentally tractable stage of T. gondii’s life cycle, as it can be easily maintained in the 
laboratory in cultured cell lines serving as host cells. During an infection, the majority of the 
tachyzoites are killed by an interferon-gamma (IFN-γ)- dependent immune response, though in 
some tissues, mostly the central nervous system and muscle, the surviving tachyzoites differentiate 
into slower growing bradyzoites. The vacuole that the parasites grow inside is modified to become 
a cyst wall. Each cyst contains hundreds of bradyzoites and is largely non-immunogenic, persisting 
for the remainder of the host organism’s life, marking the chronic stage of infection 11. Bradyzoites 
will occasionally reactivate and convert back into tachyzoites, but the immune system is able to 
prevent them from disseminating to the rest of the host. It is this reactivation that poses a threat to 
immunocompromised individuals. 
 
Figure 1. The life cycle of T. gondii 
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The asexual phase of T. gondii’s life cycle can take place in any warm-blooded animal. Acute infection is initiated in 
two primary ways, 1) accidental ingestion of environmentally stable oocysts from cat feces, or 2) ingestion of tissue 
cysts from chronically infected intermediate hosts via carnivory. In either instance, parasites from these vessels infect 
the new host’s intestinal epithelium and differentiate into the fast growing tachyzoite, marking the acute stage of the 
infection. The host immune system is able to eliminate the majority of the tachyzoites, though some differentiate into 
bradyzoites, which reside in cysts in the host’s nervous system and musculature. The development of these tissue cysts 
marks the chronic stage of infection. If a chronically infected host is devoured by another intermediate host, the 
bradyzoites are released and they mount a new infection, reverting back to tachyzoites. If the new host is a feline, the 
sexual stage of the parasite’s life cycle is initiated in the feline’s intestine, leading to the production of unsporulated 
oocysts which are shed in the feline’s feces. The unsporulated oocysts mature in the outside environment, and if 
ingested by a warm-blooded animal, can initiate an acute infection. Image created by Gregory Wier. 
 
1.2.1.1 Transmission of T. gondii in its asexual form 
The asexual bradyzoite form of T. gondii can be passed between intermediate hosts via 
carnivory. If a chronically infected organism is eaten by another animal (i.e. a chronically infected 
mouse is eaten by a hawk, or a human eats undercook meat from an infected lamb), the cyst walls 
of latent tissue cysts from the devoured organism are dissolved by proteolytic enzymes in the 
stomach of the carnivore, releasing bradyzoites, which mount an infection in the intestinal 
epithelium 8. In this way, T. gondii can be transmitted from various hosts asexually, never needing 
to transition to the sexual stage for dissemination. This is at odds with other apicomplexans, which 
have obligate two-stage life cycles and must undergo sexual reproduction before infecting a new 
intermediate host. 
1.2.2 Sexual reproduction 
The sexual stage of the parasite’s life cycle is solely confined to the intestines of felines, 
culminating with the cat shedding oocysts in its feces 12. When a cat ingests tissue cysts from a 
chronically infected organism, bradyzoites are released into the small intestine, where they infect 
the intestinal epithelial cells. After undergoing multiple rounds of asexual reproduction in the 
intestinal epithelial cells, sexual reproduction begins with the formation of male and female 
gametocytes 13,14. The male gametocyte gives rise to numerous flagellated microgametes, while 
the female gametocyte gives rise to a single macrogamete. The microgametes use their flagella to 
swim and fertilize the macrogamete, forming a zygote. After the formation of the zygote, an oocyst 
wall forms around it. These oocysts are released into the environment in the cat’s feces in an 
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immature, “unsporulated” form 14. It is in the outside environment that the oocysts fully mature, 
where they remain stable and highly infectious for months to years. If these oocysts are ingested 
by a warm-blooded animals, they can initiate an infection, leading to the reproduction of the 
parasite asexually. Due to the intractability of working with infected felines, this stage of T. 
gondii’s life cycle has received considerably less attention than the asexual stages. 
1.3 MEANS OF HUMAN INFECTION 
There are four primary ways of humans acquiring a T. gondii infection, 1) ingesting tissue 
cysts from previously infected intermediate hosts by eating raw or undercooked meat, 2) ingesting 
food or drink contaminated with oocysts from the feces of felines, 3) receiving an organ transplant 
or a blood transfusion from an infected individual, or 4) via transmission from mother to fetus if 
the mother becomes infected with T. gondii during her pregnancy. 
1.4 TREATMENTS FOR T. GONDII INFECTION 
Treatments for T. gondii infection are only available for the acute stage of infection using 
antifolate combination therapy (pyrimethamine and sulfadiazine), which can trigger severe allergic 
reactions in some patients 15. The chronic stage of T. gondii’s life cycle is refractory to current 
drugs. Because of this, the need for new and more effective pharmaceuticals is high. This need has 
prompted researchers to devote considerable effort towards understanding the unique 
morphological features of T. gondii and other apicomplexans in order to serve as potential drug 
targets. One of the most promising targets is a distinct set of morphological features for which the 
Apicomplexan phylum derives its name, the apical complex.  
1.5 UNIQUE STRUCTURAL FEATURES OF T. GONDII 
As with other Apicomplexan parasites, the obligate intracellular life cycle of T. gondii 
makes host cell invasion of paramount importance to parasite viability. The cell types which 
different Apicomplexans are able to invade is varied, from erythrocytes to macrophages. Despite 
variation in host-cell type, the modes of invasion are very well conserved. Successful host cell 
invasion is accomplished with the aid of the apical complex, a unique assembly of structural and 
secretory components at the apical end of the organisms. The apical complex not only provides 
the structure to shape the parasites, but directs a collection of secretory organelles which play an 
essential role in attachment to and invasion of the host cell 16-18. At the apical end of the complex 
is the conoid (Fig. 2), a hollow barrel of twisted microtubules which presently has no ascribed 
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function, though it is known to extend and protract when the parasite is extracellular 19. The conoid 
sits atop an apical polar ring that nucleates a collection of 22 microtubules that migrate about two 
thirds of the way down the parasite (Fig. 2) 16,20. These microtubules connect with a structure 
known as the Inner Membrane Complex (IMC), which provides structural rigidity and shape to 
the parasite. The IMC is composed of two parts 1) a collection of flattened membrane sacs known 
as alveoli, which lie just below the parasites’ plasma membrane 21, and 2) a network of intermediate 
filaments  to provide support for the alveoli 22. Together, the plasma membrane and the a IMC are 
known as the pellicle 23.  
 
Figure 2. Structural features of a T. gondii tachyziote 
A) Diagram of the tachyzoite phase of T. gondii with notable features denoted. B) An identical image to that in A, 
with the subpellicular mircotubules removed to more clearly show the underlying structures. Image created by Gregory 
Wier. 
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1.5.1 Secretory organelles 
Beyond the structural components of the apical complex, it houses two types of secretory 
organelles, the micronemes and the rhoptries (Fig. 2B). T. gondii uses these organelles to secrete 
effector proteins to assist in parasite motility and host cell invasion 24-26. The micronemes are the 
smallest of the secretory organelles, located at the very apical end of the parasite. They are 
generally thought to be the first to discharge their contents during invasion 27. The rhoptries are 
larger, bulb-shaped organelles, which primarily discharge their contents after the micronemes. 
There are two classes of proteins housed within the rhoptries, differentiated by their position within 
the organelles: 1) those positioned at the neck of organelle (rhoptry neck proteins; RONs), and 2) 
those positioned in the posterior bulb (rhoptry bulb proteins; ROPs). Several of the RONs are 
known to interact with microneme proteins during invasion, while most ROPs are involved with 
later stages of invasion and survival of the parasite after invasion 28. While not part of the apical 
complex, T. gondii also has another set of secretory organelles known as dense granules. These 
are more generally located in the cytoplasm of the parasite (Fig. 2), and play a role in modulating 
the host cell to make it a more suitable environment for parasite survival after successful invasion 
25,27. 
1.6 GLIDING MOTILITY AND HOST CELL INVASION 
T. gondii and other Apicomplexans do not have cilia or flagella, and instead use gliding 
motility for both locomotion and host cell invasion 29,30. Gliding motility and host cell invasion are 
both driven by an actin-myosin motor anchored in the parasite's pellicle. The parasite secretes a 
collection of adhesive microneme proteins to its surface which associate with receptors on the host 
cell. The myosin motor pulls along polymerized actin in the pellicle, engaging the adhesive 
microneme proteins bound to host cell receptors, applying a rearward force to propel the parasite 
forward (Fig. 3) 30. 
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 Figure 3. Gliding motility in T. gondii and other Apicomplexan parasites 
Gliding motility in T. gondii is powered by the myosin motor protein MyoA, which is anchored to the IMC by 
association with GAP50. Membrane-bound secreted microneme proteins from the TRAP adhesion family bind to 
receptors on the host cell plasma membrane, and associate with short segments of F-actin via an interaction with the 
glycolytic enzyme aldolase. MyoA pulls along the F-actin, pushing the TRAP adhesion proteins backwards and 
thrusting the parasite forward. Membrane-bound rhomboid-like proteases like ROM4 cleave the bound TRAP 
adhesion proteins in their transmembrane domain, permitting the parasite to proceed forward. Image created by 
Gregory Wier. 
1.6.1 Actin-myosin motor 
The first clues suggesting that gliding motility required actin polymerization came from 
the observation that parasites were unable to move or invade in the presence of cytoclasin D. 
Cytoclasin D is a compound which disrupts microfilament formation by binding to monomeric, 
globular actin (G-actin) and preventing it from polymerizing into filamentous actin (F-actin) 31. 
The actin-myosin motor complex that T. gondii uses to power gliding motility is anchored into the 
IMC 32. T. gondii only has a single actin gene, though it has multiple genes for myosin. The 
encoded myosin motor proteins have atypically short necks and tails, constituting a class of 
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myosins only found in Apicomplexans 33. Of these multiple myosin genes, Myosin A (MyoA) has 
been specifically implicated in both locomotion and invasion in T. gondii 34,35. MyoA is associated 
with its myosin light chain (MLC1) and two gliding-associated proteins (GAP45 and GAP50) 36,37. 
GAP50 is a integral membrane glycoprotein that is responsible for anchoring MyoA to the IMC 
36. While the function of GAP45 is currently unknown, it is anchored to the parasite's plasma 
membrane via N-terminal myristoylation, and to the IMC by its C-terminal end associating with 
GAP50 37.  
1.6.2 The generation of force 
To generate force, the IMC-anchored MyoA pulls along short segments of F-actin. F-actin, 
in turn, is linked to the cytoplasmic tails of membrane-bound microneme proteins that contact the 
extracellular environment and bind to receptors on the host cell plasma membrane (Fig. 3) 38-40. In 
Plasmodium spp. these micronemal proteins are members of the thrombospondin-related 
anonymous protein (TRAP) adhesin family, with notable orthologs in T. gondii, including 
micronemal protein 2 (MIC2) 41-43. These TRAP adhesin proteins do not contact with F-actin 
directly, rather they are linked via the tetrameric glycolytic enzyme aldolase. The force of the 
myosin pulling along the F-actin pushes the TRAP adhesin proteins rearward, driving the parasite 
forward. Disengagement of these TRAP proteins with host cell receptors is required for the parasite 
to be propelled forward, a task which is accomplished by proteolyticly cleaving the TRAP proteins 
at their transmembrane domains (Fig. 3). Understanding of this process has only recently come to 
light with the identification of some of the proteolytic enzymes involved, including rhomboid-like 
proteases (ROM4) 44,45.  
1.6.3 Host invasion 
Host cell invasion is a parasite-driven process distinct from host-mediated endocytosis, 
taking between 10 and 20 seconds (Fig. 4). Much of the same machinery utilized for gliding 
motility is also employed for host cell invasion. Secreted micronemal proteins allow the parasite 
to traverse the host cell, and then situate its apical end to the host plasma membrane, whereupon 
it discharges effector proteins from the rhopties into the host cell 27. These rhoptry proteins 
aggregate with the microneme protein Apical Membrane Antigen 1 (AMA1) to form tight ring-
shaped connection between the parasite and the host plasma membrane, known as the moving 
junction 27,28. The moving junction acts as a stable support for the parasite to actively force its way 
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into the cell using the same myosin motor employed for gliding motility 46. The rhoptry proteins 
that make up the moving junction are all rhoptry neck proteins (RONs), which are secreted as a 
complex of  RON2, RON4, RON5 and RON8 47. AMA1 is a type 1 transmembrane protein that 
sits in the parasites' plasma membrane, and makes a direct connection to RON2, which is anchored 
into the host plasma membrane 47. RON 4/5/8 are all soluble proteins that are thought to localize 
to the cytoplasm of the host cell, potentially connecting to the host cell’s cytoskeleton. RON5 is 
important for the organization of the RON proteins in the moving junction, as its deletion prevents 
RON2 and RON4 from localizing properly, and prevents the parasites from being able to invade 
host cells 48. 
 
Figure 4. T. gondii invading a host cell 
Host cell invasion is initiated when the parasite apically associated with the plasma membrane of the host cell (1). The 
parasite secretes a collection of effector proteins directly into the host cell (2), which help the parasite force its way 
into the host cell, coating itself in the host plasma membrane, forming what is known as the parasitophorous vacuole 
(3). The parasitophorous vacuole forms a close association with the host cell’s endoplasmic reticulum and 
mitochondria (4). The parasite grows and divides inside of the parasitophorous vacuole (5), before egressing from the 
host cell. Image created by Gregory Wier. 
As per its name, the moving junction “moves” down the length of the parasite towards its 
posterior, with the host plasma membrane following in its wake, enveloping the parasite as it 
pushes its way into the cell. This process creates a vacuole in which the parasite can grow and 
divide inside, known as the parasitophorous vacuole (PV) 24,26. In addition, the moving junction 
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serves as a means to filter the host plasma membrane proteins, selectively determining what host 
proteins remain in the PV 49. This exclusion process is thought to be the primary reason why the 
PV does not fuse with endosomes or lysosomes of the host 50-52. This is at odds with a parasite that 
has been coated with antibodies and is phagocytosed and degraded in the lysosome 46,51. After the 
completion of the invasion process, the parasite continues to secrete proteins from the rhoptries 
and the dense granules, which deposit themselves in the PV and the PV membrane. After numerous 
rounds of replication inside the host cell, the parasites escape from the infected host cell, resulting 
in its death (Fig. 4). The released parasites are then able to mount new infections to neighboring 
cells. Successful escape of intracellular parasites is known to be dependent on an increase in [Ca2+] 
in the parasite cytoplasm, which follows a decrease in [K+] in the cytoplasm of the host cell 53,54. 
The increase in [Ca2+] leads to an activation of parasite motility, which is needed for successful 
escape 53. 
1.7 PROTEIN TRAFFICKING IN T. GONDII AND PROTEIN PROCESSING 
Proper protein trafficking is especially important for the viability of T. gondii and other 
Apicomplexans, as all of the proteins that comprise the parasites’ secretory organelles must travel 
through it before reaching their respective organelles. In general terms, the secretory pathway 
constitutes all of the steps in which a cell transports proteins to destinations beyond their initial 
site of translation, the cytoplasm. Despite its name, not all proteins that travel through the secretory 
pathway are destined to be secreted into the extracellular environment, as membrane bound 
proteins and organellar proteins must pass through it, as well. The endoplasmic reticulum (ER) is 
the heart of the secretory pathway, as secreted proteins are sent there first to fold properly and then 
to be forwarded to their destinations, often transitioning to the Golgi apparatus, before being 
transferred to its final destination in vesicles. The ER in T. gondii is contiguous with the nuclear 
membrane, and the parasites only have a single Golgi apparatus stack 55,56. 
1.7.1 Transport into the endoplasmic reticulum 
Proteins traveling through the secretory pathway are usually co-translationally translated 
into the ER. Most secretory proteins have a short hydrophobic string of amino acids at their N-
terminus called the signal peptide which, after emerging from the ribosome, is bound by the signal-
recognition particle (SRP). This halts translation until SRP/ribosome complex is guided to an SRP 
receptor on the ER membrane. Translation resumes, stringing the nascent protein through a 
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translocon and into the ER, whereupon the signal peptide is removed by signal peptidase 57. The 
components for this process are conserved in eukaryotes, and virtually all of them are found in 
Plasmodium falciparum and T. gondii 56,58. After entering the ER, the protein finishes folding and 
is then free to be transferred to other compartments in the cell. In eukaryotes, proteins traveling 
between the ER and the Golgi apparatus bud off from their respective organelle in COPI/COPII-
coated vesicles, the components of which are present in T. gondii 59,60. 
1.7.1.1 Transport of membrane proteins into the endoplasmic reticulum 
If the protein is destined to be inserted into a membrane, that membrane association is first 
established while being co-translationally translated into the ER, with its orientation determined 
by specific topogenic sequences 61. These topogenic sequences are fall into two categories, 1) a 
stop-transfer sequence and 2) a signal-anchor sequence. Stop-transfer sequences code for a short, 
hydrophobic alpha helical segment of amino acids, and are present in many single pass membrane 
proteins. In addition to a stop-transfer sequence, these proteins have a signal peptide, which directs 
them to the ER. When the stop-transfer sequence is reached during co-translation, the protein stops 
being imported into the ER lumen. In most cases, the protein is laterally transferred into the 
membrane while translation is still occurng. Transmembrane proteins of this sort are considered 
Type I transmembrane proteins, with a single transmembrane domain, and their N-terminal region 
facing the ER lumen  61. Proteins with signal-anchor sequences do not have signal peptides, but 
are directed to the ER by virtue of their internal signal-anchor sequence, which forms a 
hydrophobic alpha helical segment. Despite functioning like a signal peptide to guide the protein 
to the ER, signal peptidase does not cleave the protein. Much like with the stop-transfer sequence, 
the hydrophobic alpha helix is what anchors the protein in the membrane. Type II and III 
transmembrane proteins are of this sort, differing in the facing of the N- and C-terminal portions 
of the protein. Type II transmembrane proteins have the N-terminus facing the cytoplasm and the 
C-terminus facing the ER lumen, and Type  III have the opposite 61. There are many proteins which 
cross the membrane more than a single time, including ion channels. These proteins are grouped 
together as Type IV transmembrane proteins, and accomplish this feat by alternating between stop-
transfer and signal-anchor sequences 61. 
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1.7.1.2 Glycosylphosphatidylinositol (GPI) anchored proteins 
Not all membrane proteins are anchored there with a hydrophobic alpha helical segment. 
Post translational modifications, in the form of glycosylation, also play a role in tethering T. gondii 
proteins to membranes. T. gondii parasites are coated with a collection of developmentally 
regulated surface antigens (SAGs) that are attached to the parasites’ plasma membrane via 
glycosylphosphatidylinositol (GPI) anchors 62,63. In fact, the vast majority of T. gondii plasma 
membrane proteins are GPI-anchored SAG proteins 63. GPI-anchored proteins have a signal 
peptide and a C-terminal stop-transfer sequence that initially anchors them into the membrane. 
After being inserted into the ER membrane by virtue of the stop-transfer sequence, the protein is 
cleaved adjacent to the stop-transfer sequence on the luminal face, releasing the protein into the 
ER lumen. The released protein is then attached to a preformed GPI membrane anchor, once again 
linking the protein to the membrane 61,64. With the GPI anchor, the protein is more free to move 
around in the ER membrane than if it was attached via a transmembrane domain. Beyond surface 
antigens, the micronemal subtilisin-like serine protease TgSUB1 is GPI anchored 65. TgSUB1 is 
secreted from the micronemes during invasion and is involved in the processing of the adhesive 
microneme protein complexes responsible for host cell attachment in gliding motility and invasion 
66.  
1.7.2 Dense granule proteins 
After a protein has been transferred to the Golgi apparatus, it is free to be transported to 
any number of destinations, including the parasite’s secretory organelles, the rhoptries, 
micronemes, and dense granules. The default destination of a soluble protein that is transferred 
through the secretory pathway is the dense granules, which are post-Golgi vesicles 67. This notion 
comes from the observation that when a signal peptide is recombinantly appended to a soluble 
protein, it is transported to the dense granules 55,56. Proteins bound for the micronemes and 
rhoptries have additional sorting sequences which direct them to their respective organelles. 
Experimentally removing these signals from Rhoptry protein 1 (ROP1) and Microneme protein 3 
(MIC3) divert the proteins to the dense granules 68,69. Many of the presently characterized dense 
granule proteins are type I transmembrane proteins that deposit themselves in the membrane of the 
PV (PVM), contributing to the maintenance of the vacuole 70. With the exception of the processing 
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of the signal peptide, most dense granule proteins do not undergo any other processing, which is 
at odds with proteins bound for the micronemes and rhoptries, which are extensively processed 56. 
1.7.3 Microneme proteins 
The majority of T. gondii microneme proteins are soluble proteins which aggregate into 
complexes inside of the ER, before being transported to the micronemes. There are three primary 
microneme protein complexes: 1) MIC1/MIC4/MIC6 68, 2) MIC3/MIC8 71, and 3) MIC2/M2AP 
72. Many of these are soluble proteins that bind to receptors on the host cell (MIC1, MIC4, and 
MIC3). Each of the complexes features a single type I transmembrane protein which anchors the 
complex to T. gondii’s plasma membrane (MIC6, MIC8, MIC2). Apart from supplying a 
membrane anchor, these transmembrane proteins often have conserved amino acid motifs in their 
cytoplasmic tails which are needed for proper microneme targeting 40. In the case of MIC6, the 
cytoplasmic domain has two tyrosine-containing motifs, SYHYY and EIEYE, which are required 
for it to be transported to the micronemes 73. Beyond having targeting sequences, some microneme 
proteins are originally synthesized as propeptides which require proteolytic maturation to be 
properly targeted to the micronemes. As an example, MIC2 is the transmembrane protein in the 
MIC2/M2AP complex, though processing of a propeptide sequence in its binding partner, M2AP, 
is needed for the complex to sort properly to the micronemes. Deletion of this propeptide sequence 
in M2AP arrests the complex in a post-Golgi compartment 74,75. 
Aside from proteolytic processing involved in sorting microneme proteins to the 
micronemes, extensive protein processing occurs after the proteins have been secreted to the 
parasite’s surface 76. In particular, there are three proteases active at the surface of T. gondii, known 
as Microneme Protein Proteases 1, 2, and 3 (MPM1, 2, 3) 76. Upon secretion to the parasite’s 
surface, several of the soluble microneme proteins are processed to expose adhesive domains 
needed to allow them to tightly bind to host cell receptors 77. This processing is believed to be 
facilitated by MPP2 and MPP3, though the identities of both MPP2 and MPP3 are currently 
unknown. MPP1 is responsible for intramembrane cleavage of the transmembrane domains of the 
MIC proteins anchored to the parasite’s plasma membrane. This causes the release of the adhesive 
microneme complexes bound to the host cell receptors, a process that is needed for efficient 
parasite motility and host cell invasion  45. The identity of MMP1 is believed to be the rhomboid-
like protease ROM4 78. 
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1.7.4 Rhoptry proteins 
Knowledge pertaining to the processing of rhoptry proteins is not as well defined as that 
for microneme proteins. Processing of rhoptry proteins is known to take place even while the 
organelle is being formed, with Rhoptry protein 1 (Rop1) being synthesized as a proprotein which 
is processed during the biogenesis of the organelle 79. Other rhoptry proteins that are synthesized 
as proproteins are processed during their trip through the secretory pathway on their way to the 
mature rhoptry organelles 80. The majority of rhoptry protein processing occurs while the protein 
transitions through the secretory pathway, and not after being secreted from the parasite, as is the 
case with many microneme proteins. Treatment of T. gondii with inhibitors to subtilisin (SUB) 
serine proteases results in the disruption of rhoptry formation and a block in parasite replication, 
implying that proteases of the subtilase family might be involved in rhoptry processing 81. T. gondii 
has 12 subtilase genes, though most have not been subjected to extensive study. T. gondii subtilisin 
2 (TgSUB2) is a rhoptry protein itself, one that is believed to play a role in the processing of 
proprotein forms of rhoptry proteins. There is a predicted TgSUB2 cleavage site in Rop1. 
Additionally, TgSUB2 co-immunoprecipitates with Rop1, suggesting that TgSUB2 might be 
responsible for Rop1 processing 81,82. Toxopain-1 is another rhoptry protease (cathepsin B-like) 
which is believed to play a role in the processing of rhoptry proteins, as treatment with cathepsin-
B inhibitors impedes rhoptry formation and parasite invasion 83.  
1.8 DEVELOPING A STRATEGY TO LABEL PARASITE PROTEINS IN THE 
CONTEXT OF THE HOST CELL 
While our understanding of how T. gondii is able to invade a host cell and grow inside it 
has made considerable progress since the discovery of the parasite in 1908 84, there is still much 
to learn. How the parasite co-opts the host cell to permit is survival is still poorly understood. The 
parasitophorous vacuole in which the parasite grows acts as the interface between the host and the 
parasite, but beyond identifying some of the parasite proteins deposited in the vacuolar membrane, 
our knowledge is lacking. Designing a system to specifically label parasite proteins while T. gondii 
grows inside of the host cell could be instrumental to shedding light on some of these questions. 
My work in the Boyle lab has focused on developing such a system, one which utilizes a 
nonstandard amino acid to specifically label T. gondii proteins.  
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The use of noncanonical amino acids for the labeling nascent proteins has been receiving 
increased traction in present years 85. In particular, the methionine (Met) analog azidohomoalanine 
(Aha) has been utilized because it has an azide functional group that can undergo a copper(I)-
catalyzed cycloaddition “click” reaction with any alkyne-containing molecule 86,87. This provides 
the opportunity to use click chemistry to append a fluorescent tag for visualization, or affinity tag 
for purification, to any Aha-containing protein. Aha is similar enough in size to Met (Fig. 5A, B) 
that it is charged to tRNAMet by a wild-type methionyl-tRNA synthetase (MetRS), such that it can 
be utilized with virtually any cell line 88-91. However, in the case of T. gondii infecting a host cell, 
Aha would get incorporated in both parasite and host proteins, making it ineffective for specifically 
labeling parasite proteins.  
To get around this problem, I have created a strain of T. gondii that expresses a mutant E. 
coli methionyl-tRNA synthetase (MetRSNLL) that is able to charge tRNAMet with the Met analog, 
azidonorleucine (Anl) 86. Anl is similar to Aha in that it also has an azide functional group, but its 
larger size prevents it from being recognized by a wild type MetRS (Fig. 5A). This means that Anl 
can only be incorporated into the proteins of cells that express the mutant form of the enzyme. So, 
in the case of the T. gondii strain expressing the mutant E. coli MetRSNLL (the Tg-MetRSNLL 
strain), Anl can be incorporated into nascent parasite proteins, but not those of the infected host 
cell. 
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 Figure 5. Methionine analogs with azide functional groups can be modified via click chemistry 
A) The structures of methionine (Met), azidohomoalanine (Aha), and azidonorleucine (Anl). B) A reaction scheme 
for the click chemistry reaction between and Anl (or Aha)-containing protein and an alkyne-containing molecule. 
Image created by Gregory Wier. 
1.9 DESCRIPTION OF THE UPCOMING CHAPTERS 
In the following chapters, I will discuss my efforts towards implementing the 
MetRSNLL/Anl labeling system in T. gondii. Chapter 2 consists of my published paper 
documenting the creation of the MetRSNLL-expressing T. gondii strain and its initial 
characterization, where I show the bacterial MetRSNLL is functional in T. gondii 92. Chapter 3 
describes the additional work that I have done to advance the project beyond what was published. 
I discuss the mass spectrometry studies that I conducted to help elucidate what Met residues are 
capable of incorporating Anl. I describe ongoing work to engineer T. gondii’s MetRS to recognize 
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Anl and charge it to both of the parasite’s tRNAMet. Furthermore, I discuss ongoing work to express 
a mutated version of murine MetRS in T. gondii, which is capable of charging Anl to both tRNAMet 
in mammalian cells. Chapter 4 summarizes my work with the MetRSNLL/Anl labeling system in T. 
gondii and offers suggestions of the steps that should be taken to see the project continue in the 
future. Chapter 5 contains all of the relevant materials and methods used for the MetRSNLL/Anl 
labeling project. Finally, the appendices describe additional projects which I have worked on 
during my time in the Boyle lab which do not fit with the overall scope of the thesis. 
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2.0 A NEW METHOD FOR THE ORTHOGONAL LABELING AND PURIFICATION 
OF TOXOPLASMA GONDII PROTEINS WHILE INSIDE OF THE HOST CELL  
What follows is a replication of my first author paper in mBio, published March 10, 2015 92. I 
wrote the paper in its entirety, and have included it here largely unmodified, with some minor 
changes to fit with the formatting of the thesis and to improve its cohesion with the remainder of 
the document. Furthermore, the Materials and Methods section of the paper was incorporated into 
Chapter 5 of the thesis. 
2.1 INTRODUCTION 
In the past several years, the use of noncanonical amino acids (NCAAs) to label newly 
synthesized proteins has expanded rapidly 85,90,93-95. Numerous methionine (Met) surrogates have 
been developed that can be activated by wild-type methionyl-tRNA synthetases (MetRS) and 
incorporated into cellular proteins. Several such surrogates carry reactive functional groups that 
allow attachment of affinity tags for protein purification or fluorescent probes for visualization. 
Among the most commonly used NCAAs are homopropargylglycine (Hpg) and azidohomoalanine 
(Aha) 88-91, both of which are susceptible to the copper(I)-catalyzed variant of the Huisgen 1,3-
dipolar cycloaddition reaction, known commonly as “click chemistry” 96-98 (Fig. 6A, B). Aha- or 
Hpg-containing proteins can be specifically labeled with alkyne or azide tags for visualization or 
purification followed by identification by mass spectrometry.  
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 Figure 6. Azidonorleucine is a methionine analog that is susceptible to modification via click chemistry 
A) The structures of methionine (Met) and methionine analogs: homopropargylglycine (Hpg), azidohomoalanine 
(Aha), and azidonorleucine (Anl). They can all be charged to tRNAMet by the wild-type MetRS, with the exception of 
Anl, which can be utilized only by a mutant synthetase like E. coli MetRSNLL.  B) Reaction scheme of a click 
cycloaddition between a protein that has incorporated Anl and an alkyne conjugated to an affinity/fluorescent tag. 
While this is a powerful approach, it does not allow monitoring of individual cell types in 
mixed cell populations, as all cell types incorporate the NCAA. This limitation prompted the 
development of cell-selective systems for NCAA incorporation. In 2009, Ngo and coworkers used 
random mutagenesis on active site residues to create a mutant version of Escherichia coli MetRS 
(the MetRSNLL strain) that activates the Met analog azidonorleucine (Anl),  which is not utilized 
by the wild-type MetRS (Fig. 6A) 86,99. This was accomplished by mutation of three highly 
conserved residues in the Met-binding pocket of the enzyme (L13N, Y260L and H301L; 
MetRSNLL) 100,101. E. coli expressing MetRSNLL (Ec:MetRSNLL) were able to use Anl in protein 
synthesis, whereas wild-type E. coli were unable to do so. Furthermore, when Ec:MetRSNLL was 
grown in co-culture with other bacterial strains or with mammalian cells, Anl was detected only 
 19  
 
in Ec:MetRSNLL proteins 86. Because MetRSNLL has a higher specificity constant (kcat/Km) for Anl 
than for Met, the growth medium does not have to be depleted of Met for effective labeling 99.  
Such a system could be extremely useful to study the interaction between the human 
parasite Toxoplasma gondii and its host.  T. gondii is an obligate intracellular protozoan parasite 
of the phylum Apicomplexan (of which the causative agent of malaria, Plasmodium spp., is part) 
and is estimated to infect up to a third of the human population 102. For this purpose, we have 
developed a T. gondii strain that heterologously expresses an HA-tagged version of E. coli 
MetRSNLL, and show that it is fully functional. 
2.2 RESULTS AND DISCUSSION 
In order to implement the MetRSNLL/Anl system in T. gondii, we heterologously expressed 
an HA-tagged version of E. coli  MetRSNLL in a type II strain of T. gondii (Me49ΔHPT:Luc 103). 
Successful expression of the bacterial gene was confirmed by comparing lysates of human foreskin 
fibroblasts (HFFs) infected with either wild type (WT) T. gondii or the MetRSNLL-expressing strain 
(the Tg-MetRSNLL strain) via western blotting (Fig. 7A). A prominent signal (at the expected 64 
kD size) is present only in the Tg-MetRSNLL strain-infected sample, confirming that E. coli 
MetRSNLL can be successfully expressed in T. gondii.  
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Figure 7. The bacterial MetRSNLL is expressed and functional in T. gondii 
A) Toxoplasma gondii is able to express the E. coli-derived MetRSNLL under control of the T. gondii GRA1 promoter. 
An HA-tagged version of MetRSNLL was expressed in a type II strain of T. gondii (Me49ΔHPT:Luc) under the control 
of the T. gondii GRA1 promoter. MetRSNLL expression was confirmed by anti-HA western blotting. Anti-Sag1 
antibody served as a loading control. B) Incorporation of Anl into proteins is limited to MetRSNLL-expressing parasite 
strains. Lysates of Anl treated human foreskin fibroblasts (HFFs) infected with either the Tg-MetRSNLL strain or WT 
T. gondii were subjected to click chemistry in the presence of biotin-alkyne. Successful biotinylation was assessed by 
probing western blots with streptavidin-HRP. C) The number of T. gondii parasites is reduced after 48 hours (h) of 
Anl exposure. The effects of growing the Tg-MetRSNLL strain in 1 mM Anl over a period of 3 days were assessed by 
a luciferase assay. Data are represented as the percent of growth in Anl compared to non-exposed controls. Growth of 
the Tg-MetRSNLL strain is reduced after 48 and 78 h of Anl-exposure.  Quantitative data are consistent with multiple 
qualitative observations of growth differences between the Tg-MetRSNLL strain and WT T. gondii in Anl. 
2.2.1 The Tg-MetRSNLL strain is able to incorporate Anl into proteins 
To determine if the Tg-MetRSNLL strain is able to incorporate Anl into nascent proteins, 
monolayers of HFFs were infected with either WT T. gondii or the Tg-MetRSNLL strain in the 
presence of 1 mM Anl for 24 hours (h). It is important to note that Met-free medium was not used, 
such that synthesis of new proteins is not dependent on the incorporation of Anl. The growth 
medium was supplemented with additional Anl after 24 h, and after a total of 48 h of growth in 
Anl, the infected HFFs were solubilized and subjected to click chemistry using a biotin-conjugated 
alkyne 104,105. Anl-incorporation was confirmed via western blotting, demonstrating that the E. coli 
MetRSNLL is functional in T. gondii, and that it is limited to parasites that express MetRSNLL (Fig. 
7B).  Furthermore, a wide variety of proteins > 21 kD are labeled only in MetRSNLL-expressing 
parasites. Taken together, these biotinylation data show that MetRSNLL is functional in T. gondii, 
and is the first demonstration of the utility of this system in any protozoan pathogen.  Moreover, 
it is likely that this system would be operational in other closely related apicomplexans, including 
Plasmodium spp. and Cryptosporidum spp. 
It should be noted that at longer exposure times, background streptavidin-HRP labeling is 
visible around 35, 45, 65, and 130 kD in both the WT and MetRSNLL-expressing samples (data not 
shown). Biotin is a cofactor that is covalently attached to a number of carboxylase enzymes, such 
as apicoplast-located acetyl coenzyme A (acetyl-CoA) carboxylase 106,107 and the mitochondrion-
located pyruvate carboxylase in T. gondii. These naturally biotinylated proteins are known to be 
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visible on streptavidin-HRP blots 106,108, so they should be visible regardless of Anl-incorporation. 
The 35 kD band is the most prominent, which may correspond to a subdomain of the multisubunit 
acetyl-coA carboxylase 106, which is prone to proteolysis in rapeseed Brassica napus 109. The 130 
kD band likely corresponds to pyruvate carboxylase, as it agrees with its predicted size.    
2.2.2 The effects of Anl-incorporation on parasite growth and protein stability 
Incorporation of Anl into nascent proteins may lead to protein misfolding or instability, 
which could be toxic or lethal to replicating parasites.  It is important to note that while the 
functional group of Anl is slightly larger than that of Met (Fig. 6A), both amino acids are nonpolar, 
suggesting that replacement of Met with Anl may not have a strongly disruptive effect on protein 
folding. Studies using a similar azide-containing methionine analog, Aha (Fig. 6A), that is capable 
of being charged to tRNAMet by a wild-type MetRS, found that the tag was non-toxic to the 
growing cells and did not significantly affect protein stability or promote degradation 88,90,110-112. 
The majority of these studies were conducted using short pulse times (2-4 h 88,110,112, up to 24 h 
111), so it remains to be seen whether prolonged exposure to Aha affects cell growth. While Anl is 
very similar in structure to Aha (Fig. 6A), it is slightly larger, and therefore cannot be charged to 
tRNAMet by a wild type MetRS. To assess the effects of Anl-incorporation, we 1) examined how 
prolonged Anl-exposure affected parasite growth and 2) globally addressed whether Anl-
incorporation affects protein stability.  
2.2.3 Examining the effect of prolonged Anl-exposure on parasite growth 
The effect of Anl-exposure on parasite growth was tested by growing either WT T. gondii 
or the Tg-MetRSNLL strain in the presence or absence of 1 mM Anl over a 72 h time period, and 
performing luciferase assays to quantify parasite replication rate. After 24 h of growth in 1 mM 
Anl, luciferase-derived signal intensity was similar between Anl-exposed and control parasite 
lysates (Fig. 7C). However, noticeable differences in parasite numbers were observed in the 
MetRSNLL-expressing strain after 48 h and 72 h of Anl exposure (55%, and 30% compared to wild 
type controls, respectively; Fig. 7C). These data suggest that incorporation of Anl leads to a 
decrease in parasite number, particularly after prolonged Anl exposure. Since this experiment was 
only performed once, no statistical analysis could be performed to give credence to the findings. 
However, a reduction in parasite number after treating the Tg-MetRSNLL strain with Anl was 
consistently observed in all subsequent labeling experiments over 48 hours. Without additional 
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experiments, it is not possible to say whether this reduction in parasite numbers is due to a change 
in growth rate, or whether it is a result of increased parasite death.  
Despite the reduced parasite numbers, parasites exposed to Anl for 48 h were still able to 
effectively invade host cells and replicate normally after Anl removal (Fig. 11, discussed later in 
text).  Parasites exposed to Anl for 72 h were also able to successfully invade host cells, as well 
(data not shown). This indicates that Anl-incorporation did not have long-term effects on parasite 
physiology and that parasites subjected to 72 h of Anl-exposure could still be used in downstream 
experiments.  While the exact mechanism of the reduction of parasite numbers is unknown, 
prolonged Anl-exposure may result in destabilization or misfolding of T. gondii proteins, leading 
to reduced parasite growth rate or increased parasite death. Regardless, Anl-exposed parasites are 
fully capable of initiating new infections, indicating that key secretory proteins involved in 
invasion remain functional after Anl-exposure. 
The reasons for the reduced parasite numbers after 48 h and 72 h of Anl exposure are 
unclear.  The Anl-exposed T. gondii parasites could be experiencing toxicity associated with 
aberrant folding of Anl-containing proteins although, compared to published studies with Anl 113 
and particularly Aha 88,110,112, the 48 h pulse time greatly exceeds typical analog pulse times.  To 
avoid complications of reduction in parasite number, we advise using Anl pulse times less than 24 
h. Importantly, if the system were to be used for pulse-chase experiments, the Anl pulse time would 
likely be considerably shorter than 24 h, such that prominent reductions in parasite numbers would 
not be observed. Indeed, pulse-chase studies utilizing Aha as a Met-analog use 2- 4 h pulse times 
to achieve substantial labeling 88,110,112. 
2.2.4 Assessing the stability of Anl-containing proteins 
An Anl pulse-chase experiment was used to globally examine the stability of Anl-
containing proteins. HFFs were infected with either WT T. gondii or the Tg-MetRSNLL strain and 
pulsed with Anl for 2 h. As expected, a biotinylated signal is only present in the Tg-MetRSNLL 
strain-infected samples (Fig. 8A, lanes 5-8). The signal intensity is the highest directly after the 
pulse, with the intensity dropping off steadily over the 6 h chase time (Fig. 8A, C). Despite the 
declining signal intensity, after the 6 h pulse there is still a sizable amount of labeled protein, with 
the signal appearing to stabilize between 3 and 6 h. These data suggest that many Anl-labeled 
parasite proteins remain stable for at least 6 h. From these data, the average half-life of Anl-
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containing proteins is approximately 7 h. Pulse-chase studies with [35S]methionine in mammalian 
cells have shown that approximately 30% of newly synthesized proteins are degraded by the 
proteasome with a half-life of <10 minutes, mainly consisting of proteins that do not  adopt their 
native fold due to translational errors 114. It remains to be determined whether a similar margin of 
proteins is degraded in T. gondii within this time frame. The possibility still exists that Anl-
incorporation has a strong destabilization effect on some proteins, leading to their rapid 
degradation by the proteasome, though those would be missed by the pulse-chase experiment 
presented here.  
 
Figure 8. Anl-labeled proteins are still present 6 h after being pulsed with Anl 
A) HFFs were infected with either WT T. gondii or the Tg-MetRSNLL strain at an MOI of 3 and grown for 48 h before 
being pulsed with 1mM Anl for 2 h. Following the 2 h pulse, Anl was washed away and the infected HFFs were 
harvested at different time points after the pulse (0, 1, 3, 6 h). Samples were biotinylated with click chemistry using 
biotin-alkyne. Successful biotinylation was assessed by western blotting and probing with streptavidin-HRP. A 
biotinylation signal is only visible in the MetRSNLL-expressing strain. The signal intensity is strongest at the 0 h time 
point, dropping steadily over a period of 6 h. B) A coomassie stained SDS-PAGE gel identical to the one used to 
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prepare the western blot in A), confirming equal protein loading. C) Quantification of the data from B). The experiment 
was conducted at least 2 times with similar results. 
 
2.2.5 Optimal Anl concentration for efficient incorporation into nascent proteins 
To optimize the MetRSNLL/Anl system in T. gondii, Anl-incorporation was examined at 
concentrations ranging from 0.1 to 4 mM over a 48 h time period (Fig. 9A, B). The levels of Anl-
incorporation with 0.5 mM and 1.0 mM Anl were similar, though there is considerably less labeling 
with 0.1 mM Anl compared to 0.5 mM and 1.0 mM (Fig. 9A, B). Based on visual inspection, 
parasite numbers were similar in 0.1 mM, 0.5 mM, and 1.0 mM Anl. However, it was apparent 
that replication was clearly reduced for parasites growing in 4.0 mM Anl. The reduction in parasite 
number was confirmed by the observed reduction in HA-tagged MetRSNLL on the western blot 
(identical “cell equivalents” were loaded for each sample; Fig. 9A). While overall Anl 
incorporation is higher in 4.0 mM Anl than in other tested Anl concentrations (Fig. 9B), the effect 
on the parasites may outweigh this benefit when large numbers of parasites are required for 
downstream experiments. However, this concentration may be useful in cases where parasite 
number is less important than overall Anl-incorporation. Taken together, these data suggest that 
1.0 mM Anl is a suitable concentration for maximizing Anl-incorporation while avoiding 
reductions in parasite number.  
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 Figure 9. 1 mM Anl is an ideal concentration for labeling, and Anl pulse times as short as 1 hour exhibit labeling 
A) Growing parasites in 1 mM Anl allows high levels of incorporation while limiting negative effects on parasite 
growth. HFFs were infected with the Tg-MetRSNLL strain at an MOI of 3 and either 0.1, 0.5, 1, or 4 mM Anl was 
added to the growth medium at the time of infection. Cells were harvested after 48 h of growth. The samples were 
biotinylated with click chemistry using biotin-alkyne. Successful biotinylation was assessed by western blotting and 
probing with streptavidin-HRP. Anti-HA western blotting for the HA-tagged MetRSNLL served as a loading control.  
B) Quantification of the data from A). The experiment was conducted at least 2 times with similar results.  C) Anl is 
incorporated into a substantial number of proteins just 1 h after being added to growth medium. HFFs were infected 
with the Tg-MetRSNLL strain at an MOI of 3 and after 2 days of growth, 1 mM Anl was added to the growth medium. 
Samples were collected at time points following Anl addition: 15 m, 30 m, 60 m, 120 m, and 240 m. The samples 
were biotinylated with click chemistry using biotin-alkyne. Western blotting with streptavidin-HRP was used to 
confirm successful labeling. D) Quantification of the data from C). The experiment was conducted at least 2 times 
with similar results. 
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2.2.6 Anl is incorporated into a substantial number of proteins 1 hour after being added to 
growth medium 
Knowing that prolonged growth in Anl slows reduces parasite numbers, we wanted to 
determine the amount of time parasites needed to be exposed to Anl for incorporation to be 
detectable. To address this question, HFFs were infected with the Tg-MetRSNLL strain and allowed 
to grow for 48 h (such that the HFFs were well-infected and would lyse the monolayer within 12 
h). After the 48 h of growth, the growth medium was supplemented with 1 mM Anl for varying 
amounts of time (15, 30, 60, 120, and 240 m). Anl was then washed from the monolayers and 
samples were harvested for click chemistry with biotin-alkyne. Western blotting was used to 
compare the levels of Anl-incorporation at the different Anl pulse times (Fig. 9C, D). Anl-
incorporation can be detected with just a 30 m Anl pulse and after an hour of Anl-exposure, a 
substantial number of proteins have incorporated Anl, based on the extensive biotinylation banding 
pattern that is observed. As expected, the level of Anl-incorporation increases with longer Anl 
pulse times, with the 4 h pulse time exhibiting the strongest signal (Fig. 9C, D). 
2.2.7 Is Anl-incorporation specific to parasite proteins? 
The utility of this approach for studying an intracellular parasite like T. gondii depends on 
the specificity of Anl-incorporation into parasite proteins. To determine if Anl-incorporation is 
specific to T. gondii proteins compared to host cell proteins, HFFs infected with WT T. gondii or 
the Tg-MetRSNLL strain were treated with Anl for 48 h, solubilized, and subjected to click 
chemistry with biotin-alkyne. The clicked samples were then used for neutravidin affinity 
purification. Anl-containing proteins were successfully purified (Fig. 10A), but only from the 
HFFs infected with the Tg-MetRSNLL strain. To assess whether host cell proteins were labeled and 
purified, an identical blot to the one in Fig. 10A was probed with an antibody against human 
GAPDH (Fig. 10B). A distinct signal at the expected 37 kD size is present in the input and unbound 
lanes of both the WT T. gondii and the Tg-MetRSNLL strain samples, though it is absent from the 
elutions. The absence of a signal from the Tg-MetRSNLL strain elutions strongly suggests that host 
cell proteins are not incorporating Anl, and are therefore not being biotinylated and purified. To 
confirm the presence of parasite proteins in the Tg-MetRSNLL strain elutions, an identical blot to 
the hGAPDH blot was probed with an anti-HA antibody to detect the parasites’ HA-tagged 
MetRSNLL (Fig. 10C). A distinct signal is seen for the HA-tagged MetRSNLL in both the input, 
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unbound, and eluted samples, but only in the Tg-MetRSNLL strain samples (at the expected 64 kD 
size). The signal intensity in the elution is approximately 30-40% of that of the input, giving a 
general estimation of the level of Anl-incorporation. The prominent signal seen in the unbound 
sample likely applies to the HA-tagged MetRSNLL that did not incorporate Anl, and therefore was 
not biotinylated and purified. These data strongly suggest that host proteins are not labeled with 
Anl during exposure in vitro, which is consistent with the fact that they have not been engineered 
to express E. coli MetRSNLL.  These data also suggest that the majority, if not all, of the biotinylated 
proteins seen in the blot from Figure 10A correspond to Anl-labeled parasite proteins. 
 
Figure 10. Anl-incorporation is limited to parasite proteins 
A) Neutravidin purification of lysates of HFFs that had been infected with either WT T. gondii or the Tg-MetRSNLL 
strain and grown in the presence of 1 mM Anl for 2 days. The samples were biotinylated with click chemistry using 
biotin-alkyne and incubated with neutravidin resin for 1 h. Biotinylated samples were eluted by boiling in SDS sample 
buffer. Labeling is only present in the Tg-MetRSNLL strain samples, where it is visible in the input (I) and elutions (E), 
and largely absent from the unbound (U) fraction. B) An identical blot to the one in A) was probed with an anti-human 
GAPDH antibody to see if host cell proteins were purified with neutravidin. A signal for hGAPDH is present in the 
input and, to a lesser extent, the unbound samples, but is absent from the elutions, suggesting that only parasite proteins 
are labeled. C) An identical blot to the one in A) was probed with an anti-HA antibody to identify the HA-tagged 
MetRSNLL. A prominent signal is seen in both the input and elution lanes of the Tg-MetRSNLL strain samples only. 
This suggests that the biontinylated proteins from A) are T. gondii proteins. 
 
2.2.8 Parasites can be labeled in situ using click chemistry 
The MetRSNLL/Anl system should allow for Anl treated parasites to be labeled in situ by 
attaching a fluorescent tag to Anl-containing proteins using click chemistry 88,113,115. To test this in 
T. gondii, we infected HFFs with WT T. gondii or the Tg-MetRSNLL strain parasites that had been 
 28  
 
pre-treated with 1 mM Anl for 48 h. Six hours post-infection, parasites were fixed and 
permeabilized. Infected HFFs were then subjected to click chemistry using an Alexa Fluor 594-
conjugated alkyne.  Tg-MetRSNLL-expressing parasites stained brightly with Alexa Fluor 594 in 
the parasite cytoplasm, while WT T. gondii parasites exposed to Anl did not.  This further confirms 
that Anl is not incorporated into host cell proteins (Fig. 11B, F).  The infected HFFs were co-
stained with the secretory protein Gra7 (Fig. 11C, G), which exhibited intense parasite staining as 
well as host cell cytosolic punctate staining, which is characteristic of this T. gondii protein 116. 
Importantly, we did not observe any such punctate staining in the Alexa Fluor 594 channel (Fig. 
11F, H), suggesting that secreted proteins like Gra7 either 1) are not tagged with Anl, 2) 
incorporate Anl but are highly unstable and therefore undetectable, 3) are not properly secreted 
from the parasite when they have incorporated Anl, or 4) are processed in a manner that removes 
all Anl-containing residues. We addressed this further in the experiments described immediately 
below.   
 
Figure 11. Anl treated parasites can be labeled in situ using click chemistry 
WT T. gondii and the Tg-MetRSNLL strain were grown in the presence of Anl for 48 h, before being used to infect 
HFFs for 6 h. After fixation and permeabilization, a click reaction was performed on the samples using Alexa Fluor 
594-alkyne (B, F). Additionally, the parasites were stained for the secreted protein Gra7 using a mouse Ab followed 
by Alexa Fluor 488 Goat Anti-Mouse IgG (C, G). The punctate Gra7 staining emanating from around the parasites 
(white arrows, C, G) is not stained with the clicked Alexa fluorophore (F), suggesting secreted proteins are not labeled. 
The channels have been overlaid in D and H. 100x magnification was used for all images. 
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2.2.9 Anl is only minimally incorporated into secreted parasite proteins 
A study by Ngo et al. showed that mammalian cells expressing the bacterial MetRSNLL 
only incorporated Anl at the N-terminal Met position in nascent proteins and not internal positions 
113. This was attributed to an incompatibility between the bacterial MetRSNLL and one of the two 
mammalian tRNAMet, the elongator tRNAMet (described further below). If this were also the case 
in T. gondii, secretory proteins would not be labeled, since the signal peptide of secreted proteins 
is cleaved during protein processing, effectively removing the N-terminal Anl residue if it had 
been incorporated. The system would also bypass most mitochondrial proteins, which have N-
terminal presequences that are removed upon successful entry into mitochondria 117. Furthermore, 
most apicoplast proteins would be missed, as they have a distinct N-terminal bipartite signal 
consisting of a classical secretory signal peptide that is removed, followed by a transit peptide 
needed for import into the apicoplast 118,119. To determine if this was a limitation in the T. 
gondii/MetRSNLL/Anl system, parasites were grown in the presence of 1 mM Anl for 2 days, 
solubilized and proteins were biotinylated with click chemistry. The biotinylated samples were 
then purified with neutravidin resin and run on a western blot probing for the secreted T. gondii 
protein Rhoptry protein 7 (Rop7; Fig. 12B) and biotinylated proteins with streptavidin-HRP (Fig. 
2-7A). The prevalent signal in both the input and elution samples on the streptavidin-HRP blot 
(Fig. 12A) implies that a sizeable number of parasite proteins incorporate Anl, allowing them to 
be biotinylated and purified. However, the absence of a signal in the elution on the Rop7 blot (Fig. 
12B) implies that Rop7 cannot be purified, potentially because it 1) does not incorporate Anl, 2) 
any incorporated Anl gets removed via processing, or 3) incorporation destabilizes the protein 
causing it to be degraded.  
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 Figure 12. Proteins from T. gondii parasites grown in the presence of Anl can be biotinylated with click 
chemistry, though secreted rhoptry proteins are minimally labeled 
A) A western blot of a neutravidin purification of biotinylated parasite proteins, probed with streptavidin-HRP. HFFs 
were infected with the Tg-MetRSNLL strain in the presence of 1 mM Anl, and solubilized after 2 days of growth. Anl-
containing proteins were biotinylated with click chemistry and purified with neutravidin resin.  There is a strong signal 
in both the input (I) and elution (E), suggesting that a sizeable number of proteins were successfully purified. Note: 
the large amount of biotinylated protein in each lane resulted in a rapid depletion of the chemiluminescent substrate, 
hence the lack of signal in the internal portion of the input lane. B) An identical blot to the one in A), probed for the 
secreted parasite rhoptry protein 7 (Rop7). The absence of a signal for Rop7 in the elution sample suggests that it did 
not incorporate Anl, and therefore was not biotinylated. C) A western blot of a neutravidin purification of biotinylated 
proteins from HFFs infected with either WT T. gondii or the Tg-MetRSNLL strain and probed with an anti-rhoptry 
protein 5 (Rop5) antibody. The blot was overexposed, revealing a signal for Rop5 in the elution of the Tg-MetRSNLL 
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strain sample. D) The blot from C) was stripped and reprobed with and anti-rhoptry protein 18 (Rop18) antibody. As 
with C), the blot was overexposed, revealing a signal for Rop18 in the elution of the Tg-MetRSNLL strain. E) The 
samples used to prepare C) and D) were used for a new blot, where the input and unbound samples were diluted 50 
fold and the elution samples were undiluted. The blot was probed with an anti-Rop5 antibody, revealing Rop5 signal 
in both the WT T. gondii and the Tg-MetRSNLL strain elutions. F) The blot from E) was stripped and reprobed with an 
anti-HA antibody to identify the HA-tagged MetRSNLL. 
 
To investigate whether other secreted proteins could be purified, additional neutravidin 
purifications were performed, using HFFs infected with either WT T. gondii or the Tg-MetRSNLL 
strain, and probed for the secreted parasite proteins Rhoptry protein 5 (Rop5; Fig. 12C) and 
Rhoptry protein 18 (Rop18; Fig. 12D). Interestingly, a signal is visible in the Tg-MetRSNLL strain 
elutions only when the blots are overexposed (Fig. 12C, D). In both cases, the clear disparity 
between signal intensities in the input/unbound and the elutions implies that both Rop5 and Rop18 
are very minimally labeled. This is at odds with the purified HA-tagged MetRSNLL (Fig. 10C), 
which suggests around 30-40% of the HA-tagged MetRSNLL population is labeled and purified. If 
both the input and unbound samples are diluted by a factor of 50 and the elution samples remains 
undiluted, a Rop5 western blot reveals that there is purified Rop5 in the elutions from both the WT 
T. gondii and the Tg-MetRSNLL strain samples (Fig. 12E). The Rop5 signal in the WT T. gondii 
elution is perplexing, though it may correspond to Rop5 protein that nonspecifically adheres to the 
resin used in the purification. Importantly, the Rop5 signal seen in the Tg-MetRSNLL strain elution 
is approximately 2x the intensity of the WT T. gondii elution, implying that there was some 
enrichment beyond the background level seen in the WT T. gondii sample. The Rop5 blot was 
stripped and reprobed with an anti-HA antibody, revealing a strong signal for the HA-tagged 
MetRSNLL only in the Tg-MetRSNLL strain elution sample (Fig. 12F), a signal considerably 
stronger than that of the eluted Rop5. These neutravidin purification data are consistent with the 
lack of any host cell cytoplasmic labeling in the in situ tagging experiments described in Figure 
11.  While it would be expected that the cytoplasmic signal from Anl-tagged (and therefore Alexa 
Fluor 594-labeled) proteins would be observed, we did not observe any evidence that Anl-tagged 
proteins could be found in multiple known locations for T. gondii secreted proteins (primarily the 
host cell nucleus, as well as in cytoplasmic puncta).  It has been well-established that multiple 
rhoptry and dense granule proteins can be found in these host cell locations. 
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 Figure 13. The bacterial MetRSNLL cannot charge Anl to T. gondii elongator tRNAMet 
A) Bacterial MetRS (wild type or the NLL mutant) cannot charge eukaryotic elongator tRNAMet. B) A diagram of the 
ribosome reading mRNA to synthesize a protein. Since the initiator tRNAMet can be charged with Anl, it gets 
incorporated into the protein. The elongator tRNAMet cannot be charged with Anl, so all of the internal Met sites stay 
as Met. C) The secondary structure prediction of T. gondii initiator tRNAMet (gene models: TGME49_269820, 
TGME49_248915, TGME49_248925). Bases 31 and 39 form a Watson-Crick base pair in the anticodon loop. D) The 
secondary structure prediction of T. gondii elongator tRNAMet (gene models: TGME49_212750, TGME49_202895, 
TGME49_257140). Bases 31 and 39 cannot form a Watson-Crick base pair, increasing the size of the anticodon loop. 
The models in C and D were generated with tRNAscan-SE 1.21 using sequences from the T. gondii Me49 strain from 
ToxoDB.org. 
The most likely explanation for the minimal labeling of secretory proteins is that only the 
initiator methionine is replaced with Anl, while internal Met residues are not. This stems from the 
fact that there are two tRNAMet in prokaryotes and eukaryotes, the initiator tRNAMet, which carries 
the first Met, and the elongator tRNAMet, which carries all of the internal Met residues 120. 
Normally, MetRS is responsible for attaching Met to both the initiator and elongator tRNAMet. 
However, a bacterial MetRS cannot attach Met (or Anl) to a eukaryotic elongator tRNAMet, only 
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an initiator tRNAMet (Fig. 13A) 120-123. The reason for this inability was suggested to be due to a 
difference in the size of the anticodon loop of the eukaryotic elongator tRNAMet 124, which is one 
of the key determinants for tRNAMet binding to the MetRS 125. The initiator and elongator tRNAMet 
from E. coli both have a base pair between residues 31 and 39, which forms a 7 base anticodon 
loop. In T. gondii (and most other eukaryotes), the anticodon loop is 7 bases in the initiator 
tRNAMet (Fig. 13C), but is predicted to be 9 bases in the elongator tRNAMet, due to a lack of base 
pairing between residues 31 and 39 (Fig. 13D). Making a single nucleotide change to introduce a 
Watson-Crick base pair between residues 31 and 39 in rabbit elongator tRNAMet was enough for 
the tRNAMet to be aminoacylated by a bacterial MetRS 124. Taken together, these data suggest that 
the E. coli MetRSNLL system is similarly incapable of replacing internal Met residues with Anl, 
and therefore proteins processed via the secretory pathway would be undetectable in the Tg-
MetRSNLL strain.  The inability to identify Rop7 in pulldowns and the in situ data in Figure 11 are 
consistent with this explanation.  The small amount of labeled and purified Rop5 and Rop18 may 
correspond to newly synthesized protein that has not yet fully transitioned through the secretory 
pathway to the rhoptries. Another possible explanation for the low labeling of secreted proteins is 
that they are more susceptible to misfolding than other classes of proteins upon Anl incorporation, 
and are more readily degraded by quality control machinery.  
If only the N-terminal Met residue can be replaced by Anl, the label could still be removed 
by methionine aminopeptidases.  These enzymes are responsible for removing the N-terminal Met 
residue from cytoplasmic proteins that are not otherwise processed 126. This could add further 
complications to effectively using the MetRSNLL/Anl system. When Ngo et al. expressed the 
bacterial MetRSNLL in mammalian cells, they found that a N-terminal Anl residue could be 
removed by methionine aminopeptidase, though the rate of removal was at least three times slower 
than that of Met 113. This suggests that the bacterial MetRSNLL/Anl system will still be useful for 
examining methionine aminopeptidase targets, but the labeling may be slightly reduced due to this 
processing. T. gondii has at least two putative methionine aminopeptidases, so this form of N-
terminal processing needs to be accounted for when utilizing the MetRSNLL/Anl system in the 
parasite. GAPDH is a known target of methionine aminopeptidase-2 (MetAP2) in human cells 127, 
which could account for the inability to purify hGAPDH from Anl-labeled samples (Fig. 10).  
However, the Anl-containing N-terminal residue would be expected to be detectable at some level 
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in labeled cells given the predicted decrease in processing rate associated with N-terminal Anl 
residues 113.  Other host cell proteins that are not targets of aminopeptidases should be examined 
in future studies to further confirm the orthogonality of the T. gondii Anl system.  . 
Which specific Met residues can be replaced by Anl will be addressed further in future 
studies using mass spectrometry and genetics will be used to mutate the endogenous T. gondii 
MetRS to incorporate Anl. 
2.3 SUMMARY 
Combining click chemistry and the incorporation of azide/alkyne-containing NCAAs into 
nascent proteins is finding increasing use in the study of protein synthesis and degradation. A 
combination of Aha-incorporation/click chemistry and ribosomal RNA (rRNA)-targeted 
fluorescence in situ hybridization (FISH) has been used to monitor protein synthesis in diverse 
microbial populations 115. Zhang and colleagues used Aha-incorporation to monitor the 
degradation of long-standing proteins via autophagy 128. These examples are all using a NCAA 
which can be incorporated into virtually any protein, as the NCAAs are recognized by wild type 
aminoacyl-tRNA synthetases. This poses a problem when trying to use the system for studying 
specific cell types in a varied population, in that all the cell types can incorporate the NCAA. To 
surmount this problem, we have employed a system that was developed by Ngo et al., using a 
mutant form of methionyl-tRNA synthetase (MetRSNLL) in T. gondii, allowing the azide-
containing Met analog, azidonorleucine (Anl), to be incorporated in nascent parasite proteins 86,99. 
This system is highly effective at labeling nascent proteins in T. gondii, and is orthogonal, labeling 
proteins only in MetRSNLL-expressing parasites. The Tg-MetRSNLL strain is a new tool to study 
novel aspects of parasite protein expression while parasites are growing inside of infected host 
cells, and strains and plasmids will be given freely upon request.  However, our data also show 
that, in T. gondii, proteins which are N-terminally processed, like those destined for secretory 
organelles like the dense granules and the rhoptries, are only very minimally labeled.  This method 
could potentially be used to determine which secreted proteins, and apicoplast/mitochondria-
located proteins, are not N-terminally processed. We will address the mechanism for this labeling 
specificity, as well as how to label N-terminally processed parasite proteins with Anl, in future 
studies. A study in the pathogenic bacteria Yersinia enterocolitica used the MetRSNLL/Anl system 
to identify proteins that it secreted in HeLa cells 129, providing evidence that the system should be 
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applicable to studying/identifying secreted proteins in apicomplexan parasites, like T. gondii, if 
system can be modified to label N-terminally processed proteins. 
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3.0 FURTHER ADVANCEMENTS OF THE METRSNLL/ANL SYSTEM 
3.1 INTRODUCTION 
While it is evident that the MetRSNLL/azidonorleucine (Anl) labeling system is functional 
in T. gondii, more work is necessary to better characterize the system, and to improve upon it such 
that it more completely labels T. gondii proteins. It is likely that the T. gondii strain expressing the 
bacterial MetRSNLL (the Tg-MetRSNLL strain) is only able to charge its initiator tRNAMet with Anl, 
and not its enlongator tRNAMet. As such, only the Met residue that initiates protein synthesis can 
be substituted with Anl, and all internal Met residues cannot be replaced with Anl. The minimal 
labeling of secreted parasite proteins supports this notion (Section 2.4.9), as many secreted proteins 
are subjected to N-terminal processing during their transition through the secretory pathway, 
effectively removing the Anl tag if it had been added. Moreover, even proteins not destined for the 
secretory pathway may be subject to elimination of the N-terminal residue by aminopeptidases, 
further decreasing the efficiency of the system.  More conclusive data is needed to confirm that it 
is only the initial Met residue that can incorporate Anl. Presupposing this notion to be the case, 
there is the possibility that T. gondii’s MetRS gene could be mutated to code for a version of 
protein which is able to recognize Anl. Since this would be utilizing the parasite’s own MetRS, it 
is likely that it would be able to effectively bind both the initiator tRNAMet and the elongator 
tRNAMet, ensuring that Anl would be incorporated at all Met positions. 
In this section, I will describe the additional efforts that have I have made to further 
characterize the MetRSNLL/Anl labeling system, and those to improve the system. Specifically, I 
will describe 1) the mass spectrometry experiments that I performed, 2) my efforts to mutate T. 
gondii’s MetRS to charge tRNAMet with Anl, and 3) my efforts to express a mutated version of the 
murine MetRS in T. gondii, one capable of charging Anl to both eukaryotic tRNAMet. 
3.2 MASS SPECTROMETRY 
While it has been confirmed that Anl is successfully incorporated into parasite proteins in 
the Tg-MetRSNLL strain (Section 2.4.1, 2.4.7, 2.4.9), the specific identity of the majority of the 
labeled proteins remains unknown. Furthermore, which Met residues are replaced by Anl is 
unknown, though it is likely that only the N-terminal Met residue can incorporate the analog 
(Section 2.4.9) 113. To address these outstanding questions, I have conducted a series of mass 
spectrometry experiments, aimed at identifying specific proteins that incorporate Anl, and at what 
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Met positions the analog is incorporated. I have conducted several mass spectrometry experiments 
with a numerous collaborators, though they have been largely inconclusive. I performed mass 
spectrometry analysis on four different sample types: 1) infected host cell lysates which were 
treated with Anl, 2) purified parasites which were grown in the presence of Anl, 3) neutravidin-
purified Anl-containing proteins, and 4) immunopurified HA-tagged MetRSNLL.  
In the present section, I will describe how Anl is recognized via mass spectrometry, 
followed by a summary of the mass spectrometry experiments performed on the aforementioned 
sample types. 
3.2.1 Differentiating Anl from Met using mass spectrometry 
Met differs from Anl by the addition of C, H, N3, and the loss of S, differences that are 
readily detectable via mass spectrometry by an increase in molecular mass (Fig. 14). Mass 
spectrometry data analysis software, like Mascot, can be programed to specifically look for this 
change in mass at Met residues 130. The conversion of Met to Anl is marked by a monoisotopic 
mass increase of 23.04 Da (Fig. 14). Some elements have natural isotopes that are present at low 
abundance in nature, which contribute to the mass of identified protein fragments. The 
monoisotopic mass is the mass of a molecule without the contribution of any of these stable 
isotopes. Many mass spectrometers have the resolving power to differentiate between the 
monoisotopic variant of a peptide, and those which feature various stable isotopes. Complicated 
molecules like peptides feature a large number of elements, such that stable isotopes can be highly 
represented. Based on the abundance of particular isotopes in nature, the contributions of each can 
be estimated for a molecule, and an average mass value for a particular molecule can be determined 
131. In the case of the conversion of Met to Anl, the average mass increase is 22.97 Da. 
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 Figure 14. The structures of methionine and azidonorleucine 
3.2.2 Analysis of infected host cell lysates which were treated with Anl 
As the simplest means to look for Anl-incorporation into parasite proteins, I grew parasites 
in human foreskin fibroblasts (HFFs) in the presence of Anl and sent solubilized samples of the 
infected host cells for mass spectrometry analysis. Since whole cell lysates were used in these 
experiments, host cell proteins would be identified alongside of parasite proteins, ideally 
demonstrating that the incorporation of Anl was specific to parasite proteins. 
Specifically, HFFs were infected with either WT T. gondii or the Tg-MetRSNLL strain and 
grown in the presence of Anl for 2 days. This time period allowed sufficient time for parasite 
replication and incorporation of Anl into nascent proteins. The WT T. gondii strain served as a 
negative control, as it did not express the bacterial MetRSNLL, such that it should not be able to 
incorporate Anl into proteins. After the 2 days of growth, the infected HFFs were washed with 
PBS to remove unincorporated Anl. The HFFs were then solubilized directly with the RIPA buffer 
(prepared from Sigma-Aldrich’s Mammalian Cell lysis kit). RIPA buffer is a lysis buffer that is 
commonly used for protein solubilization, though it mild enough to maintain the biological activity 
of most proteins and their binding interactions 132. Due to the mild nature of the lysis buffer used, 
it is likely that not all proteins were fully solubilized and that some host and parasite proteins were 
missed. After solubilization, the samples were centrifuged at 12,000xg for 10 minutes to pellet the 
cellular debris. The supernatant was removed and sent for mass spectrometry analysis. 
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I prepared two sets of samples in this fashion. For the first sample (02.28.12), 7 T25 culture 
flasks of HFFs were infected per strain (WT T. gondii and the Tg-MetRSNLL strain). After 2 days 
of growth in Anl, the infected HFFs were combined, based on strain, in a total of 1ml of RIPA 
buffer. The protein concentration in the samples was low, as determined with Life Technologies’ 
EZQ Protein Quantitation Kit (WT T. gondii ~0.94 µg/ul and Tg-MetRSNLL strain ~0.99 µg/ul). 
For the second sample (07.09.12), 8 T25s of HFFs were used per strain, and the samples were 
prepared as the first, with the exception that after solubilizing the samples in RIPA buffer, they 
were centrifuged in an ultracentrifuge at 100,000xg for 45 minutes. In this instance, the samples 
were considerably more concentrated (WT T. gondii ~5.75 µg/ul and Tg-MetRSNLL strain ~5.57 
µg/ul). These samples were sent to Dr. Philip C. Andrews at the University of Michigan Medical 
School for analysis.  
I performed a click reaction on a small portion of the second set of samples to see if any of 
the proteins had successfully incorporated Anl. The click reaction was performed on both the WT 
T. gondii and the Tg-MetRSNLL strain samples, using Alexa Fluor 488 alkyne. This should result 
in appending a fluorescent tag to any proteins which incorporated Anl. The clicked samples were 
run on an SDS-PAGE gel and imaged on a fluorescent gel reader. As expected, there is a 
fluorescent signal seen in the Tg-MetRSNLL strain samples, but it is largely absent from the WT T. 
gondii samples (Fig. 15A). This confirmed the notion that Anl-labeled proteins were amongst the 
sample sent for mass spectrometry analysis, but the relatively weak signal compared to its 
coomassie stained counterpart (Fig. 15B) suggests that a large margin of the proteins in the sample 
did not incorporate Anl, or that click labeling with the fluorescent tag was not very efficient.  
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 Figure 15. The protein samples sent to Dr. Philip Andrews’ laboratory for mass spectrometry analysis contain 
proteins which have incorporated Anl 
A) Fluorescent gel of lysates of Anl treated, T. gondii-infected HFFs sent to Dr. Phillip Andrews’ laboratory for mass spectrometry 
analysis. HFFs were infected with either WT T. gondii or the Tg-MetRSNLL strain at a MOI of 3 in the presence of 1 mM Anl. After 
2 days of growth, the HFFs were washed with PBS to remove excess Anl, and were then solubilized in RIPA buffer. A portion of 
the samples were subjected to click chemistry with Alexa Fluor 488 and then run on an SDS-PAGE gel. The gel was analyzed on 
a fluorescent gel reader. The gel was cropped to remove lanes not pertinent to the experiment. B) A coomassie stain of the gel from 
A. C) Fluorescent gel of purified parasite samples isolated from Anl treated, T. gondii-infected HFFs, samples which were sent to 
Dr. Phillip Andrews’ laboratory for mass spectrometry analysis. HFFs were infected with either WT T. gondii or the Tg-MetRSNLL 
strain at a MOI of 3 in the presence of 1 mM Anl. After 2 days of growth, the HFFs were washed with PBS to remove excess Anl, 
and the parasites were isolated from the HFFs via needle passage. Parasites were purified by filtration through a 5.0 µm filter and 
were then solubilized in RIPA buffer. A portion of the samples were subjected to click chemistry with Alexa Fluor 488 and then 
run on an SDS-PAGE gel. A sample prepared from HFFs infected with the Tg-MetRSNLL strain in the presence of Anl served as a 
positive control. D) A coomassie stain of the gel from C. 
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3.2.2.1 Results 
Of these two sets of samples, I received data from only the first set. The samples were 
trypsinized and subjected to MS/MS analysis with a 4800 Plus MALDI TOF/TOF Analyzer. The 
peptide fragments were assigned to their respective proteins by comparing the masses to a database 
containing predicted trypsinized products of all human and T. gondii proteins. From these data, 
there were 105 distinct proteins represented from the WT T. gondii samples, and 242 from the Tg-
MetRSNLL strain samples, many of which were covered by multiple peptide fragments. Both 
samples featured similar protein profiles, including prominent surface antigens, secreted rhoptry 
proteins, and metabolic enzymes like glyceraldehyde 3-phosphate dehydrogenase and 
phosphofructokinase. Anl was only found in two peptide fragments from the Tg-MetRSNLL strain 
samples. One of these was the host cell protein Sister chromatid cohesion protein DCC1, and the 
other was a hypothetical parasite protein on chromosome III. In both of these cases, the Met residue 
replaced with Anl was an internal Met residue. For the hypothetical T. gondii protein, the replaced 
Met residue was near the C-terminus of the protein.  
Of the 105 distinct proteins from the WT T. gondii samples, only 28 of them were 
represented with peptide fragments containing Met. Most of these were only represented by a 
single fragment. Only one of the peptide fragments featured the initiating N-terminal Met residue 
(polynucleotide 5’-hydroxyl-kinase). Of the 242 distinct proteins from the Tg-MetRSNLL strain 
samples, only 26 of them were represented with peptide fragments containing Met, none of which 
were the N-terminal Met residue.  
In the infected host cell lysates, between 80-86% of the peptide fragments were from host 
cell proteins. Due to the extremely small number of proteins that were identified with Anl, it seems 
unlikely that either of the identifications are legitimate. Performing mass spectrometry on purified 
Anl-treated parasites, as opposed to infected host cell lysates, would help to increase sequence 
coverage of T. gondii proteins. 
3.2.3 Analysis of purified parasites which were grown in the presence of Anl 
The second set of samples that were subjected to mass spectrometry analysis where of 
purified parasites. Ideally, by focusing the analysis specifically on parasite proteins, the percent 
protein coverage would increase, as the samples would largely be devoid of host proteins.  
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For these experiments, HFFs were infected with parasites in the presence of Anl, and 
instead of solubilizing the HFFs directly, the cells were syringe lysed by needle passage to release 
the parasites. The lysed host cell mixture was then passed through a 5.0 µm syringe-driven filter 
to remove host cell debris. Parasites are small enough to pass through the 5.0 µm pores in the 
filters. The released parasites were pelleted via centrifugation at 800xg and then solubilized in 
RIPA buffer. This method removed the majority of host cell proteins from the sample, such that 
the majority of the peptide fragments analyzed were of parasite origin. 
I prepared three sets of samples in this fashion. The first two sets were sent to Dr. Andrews’ 
laboratory for analysis. The first sample (06.14.12) was prepared by infecting 10 T25 culture flasks 
of HFFs per strain (WT T. gondii and the Tg-MetRSNLL strain). Low protein concentrations 
prompted me to prepare a second sample (07.18.12) using 15 T25 culture flasks of HFFs per 
parasite strain. Protein concentrations were considerably higher in this instance, as determined by 
the EZQ Protein Quantitation Kit (WT T. gondii ~2.98 µg/ul and Tg-MetRSNLL strain ~1.28 µg/ul). 
To confirm Anl incorporation in the samples, a click reaction was performed on the samples using 
Alexa Fluor 488 alkyne, and the samples were run on an SDS-PAGE gel and analyzed for 
fluorescence. There is a prominent fluorescent signal in the Tg-MetRSNLL strain sample, but not 
in the WT T. gondii sample (Fig. 15C). A comparison of the coomassie stained signal with the 
fluorescent signal (Fig. 15C, D) suggests that a large portion of the protein in the Tg-MetRSNLL 
strain sample contains Anl. No mass spectrometry data were obtained from these two samples due 
to experimental failure during sample processing. The third set of samples was prepared using 10 
T25 culture flasks of HFFs per parasite strain and was sent to Dr. Louis M. Weiss at the Albert 
Einstein College of Medicine, who has considerable experience with T. gondii proteomics 133-136. 
3.2.3.1 Results 
From the mass spectrometry analysis of the samples sent to Dr. Weiss, a total of 1279 
distinct proteins were identified, each being represented by a minimum of 2 peptides. The vast 
majority of these proteins were of parasite origin (978), with 60% being common between both 
samples and 27% and 13% being unique to WT T. gondii and the Tg-MetRSNLL strain, 
respectively. Amongst these proteins, 24 were predicted to have incorporated Anl, though 8 were 
human proteins, such that 3% of the identified human proteins incorporated the analog. Of the 16 
remaining T. gondii proteins with Anl, 5 of them exhibited poor percent protein coverage, 2 of 
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which were not tryptic digests calling them into further question (Table 1). Of the 11 T. gondii 
proteins which featured Anl, some fragments contained Anl at multiple Met residues. Furthermore, 
none of the replaced Met residues were the initiating Met residue.. The majority of the proteins 
that incorporated Anl are not predicted to have signal peptides. Of the 1,279 proteins identified 
between the two samples, only 11 proteins could be confidently assigned to have incorporated Anl, 
indicating that Anl was incorporated at very low levels (1%).  
Some of the identified peptides were from highly abundant parasite proteins (heat shock 
protein 90 and fructose-1,6-bisphosphate aldolase) which might not have been fully removed from 
the enrichment procedure. As a means to help differentiate from contaminating proteins in future 
studies, the Anl pulse could be performed simultaneously with a pulse of heavy lysine ([13C6, 
15N2]lysine). Only proteins that incorporated the heavy lysine would be considered as legitimate 
hits, with those lacking the isotopic label representing proteins synthesized before the pulse, and 
likely corresponding to proteins that were non-specifically purified 113. 
The incorporation of Anl at internal Met positions is at odds with the findings of Ngo and 
co-workers when they expressed the bacterial MetRSNLL in mammalian cells 113. However, the 
extremely low number of proteins featuring Anl, both in host and parasite proteins, suggests that 
the identified Anl-containing fragments might have been misidentified. A way to help determine 
this would be to do a virtual tryptic digest of the proteome of an organism not used in the 
experiment, potentially a strain of yeast, and compare the identified mass values to the virtual 
digest. Since there should be no yeast proteins in the sample, ideally no Anl-containing yeast 
proteins should be identified. If some are identified, and this number is similar to the number of 
Anl-containing host cell/parasite proteins assigned, it would suggest they were background noise 
and were misidentified. 
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Table 1. Anl-containing proteins from a mass spectrometry analysis of purified parasite samples 
 Protein 
name 
% 
coverage 
Unique 
peptide
s (#) 
Signal 
peptide 
Anl-containing fragment 
(Anl denoted by lowercase “m”) 
Notes 
01 heat shock 
protein 90, 
putative 
38% 32 Yes LPENQPNIYYAAGESAEQLmKAPE
mQIFLKK 
N-terminus not 
represented 
02 fructose-
1,6-
bisphosphat
e aldolase 
37% 21 No mSGYGLPISQEVAK N-terminus not 
represented 
03 ribosomal 
protein 
RPS6 
30% 8 No QGFPmmQGVLVNHR N-terminus not 
represented 
04 prolyl-
tRNA 
synthetase 
22% 13 No LADEELLGPmLDVSKGSVTPLAAm N-terminus not 
represented 
05 bifunctional 
dihydrofolat
e reductase-
thymidylate 
synthase 
19% 10 No FGCTmRYSLDQAFPLLTTK N-terminus not 
represented 
06 protein 
phosphatase 
2C domain-
containing 
protein 
15% 6 No QTmEDAHIATPSLR N-terminus not 
represented 
07 sarco/endop
lasmic 
reticulum 
Ca2+-
ATPase 
14% 10 No QADIGVAmGIAGTEVAK N-terminus not 
represented 
08 AMP-
binding 
enzyme 
domain-
containing 
protein 
14% 10 No IFTIVYTSGTTGNPKGVmmSNR N-terminus not 
represented 
09 rhoptry 
metalloprot
ease 
toxolysin 
TLN1 
13% 19 Yes HLmHSRVTAPSNVLASVQSSR N-terminus not 
represented 
10 Inner 
Membrane 
Complex 
Protein 17 
12% 10 No QQmEEDTEATEVEKK N-terminus not 
represented 
11 cysteine-
tRNA 
synthetase 
12% 7 Yes YIFHmLKIFGVVEDDEDNMAYVK N-terminus not 
represented 
12 hypothetical 
protein 
5% 6 No NISLEQANALVSKCmHNm Chrom. VI, N-
terminus not 
represented 
13 hypothetical 
protein 
4% 3 No QMQGWDmVQKEGK & 
LEKYQEATEEAEKELEKm 
Chrom. X, 
questionable 
based on 
MS/MS, N-
terminus not 
represented 
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14 hypothetical 
protein 
2% 1 No MTAGKEGAGm N-terminal 
peptide, 
Not tryptic 
peptide 
fragment 
15 hypothetical 
protein 
2% 4 No LQNQGAKSEDPmGSEKQK 
 
Chrom. XII, N-
terminus not 
represented 
16 DEAD/DE
AH box 
helicase 
domain-
containing 
protein 
1% 1 No TIAMKTQSENTADDPLDAFm N-terminus not 
represented, 
questionable 
based on 
MS/MS, Not 
tryptic peptide 
fragment 
 
3.3.4 Analysis of neutravidin-purified Anl-containing proteins  
Based on the limited number of peptide fragments containing Anl in the purified parasite 
samples, I decided to specifically isolate Anl-containing proteins by biotinylating them with click 
chemistry and purifying them with neutravidin resin. Then, rather than trying to elute the 
biotinylated proteins from the resin, I sent the resin to the Weiss laboratory to be trypsinized 
directly. The biotin-neutravidin interaction is extremely strong, such that the only means of eluting 
the bound protein is by boiling the resin in sodium dodecyl sulfate (SDS) sample buffer. 
Unfortunately, the addition of SDS renders the samples incompatible for mass spectrometry 
analysis 137. Barring non-specific binding to the resin, this method should limit the proteins 
analyzed to those that actually incorporated Anl. 
To prepare the samples for analysis, 3 T25 culture flasks of HFFs were infected per strain 
(WT T. gondii and the Tg-MetRSNLL strain) in the presence of 1 mM Anl. After 2 days of growth, 
the parasites were released from the HFFs by needle passage and pelleted via centrifugation. The 
pelleted parasites were solubilized in RIPA buffer and centrifuged at 12,000xg for 10 minutes to 
pellet the cellular debris, whereupon the supernatant was saved for click chemistry. After 
biotinylating any Anl-containing proteins with click chemistry, the samples were incubated with 
neutravidin resin for 2 hours. The resin was washed with PBS, and then sent to the Weiss 
laboratory to be trypsinized and analyzed.  
Trypsinizing the biotinylated proteins should generate a collection of peptide fragments for 
identification by mass spectrometry, though the fragments actually containing Anl would not be 
identified, as they should be biotinylated and still bound to the resin (assuming that 100% of the 
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Anl residues are biotinylated from the click reaction). Any of the identified peptide fragments 
could have been from a biotinylated protein, or from a protein which nonspecifically bound to the 
neutravidin resin. Performing the experiment with both WT T. gondii and the Tg-MetRSNLL strain 
was done to help differentiate between these two possibilities. Since the WT T. gondii do not 
express the bacterial MetRSNLL, they should not be able to incorporate Anl into their proteins and, 
therefore, cannot be biotinylated. So, any parasite proteins identified from the WT T. gondii 
samples would be the result of nonspecific binding to the resin. A protein identified only in the 
Tg-MetRSNLL strain samples, and not the WT T. gondii samples, would be a strong candidate for 
an Anl-containing protein. 
The large majority of the proteins identified in the experiment were human proteins. Of the 
T. gondii proteins that were identified, none of them were solely confined to samples from the Tg-
MetRSNLL strain. In fact, very few of the identified parasite proteins were from the Tg-MetRSNLL 
strain. Why this was the case is uncertain, though if the experiment were to be repeated, more 
parasites should be used to generate the samples to increase the concentration of parasite proteins 
being handled. Some of the identified T. gondii proteins included actin, heat shock protein 70 
(HSP70), and nitrate reductase. These are highly abundant proteins, so it is likely that they were 
not specifically purified, and are remnants that were not completely removed in the purification 
procedure. 
Future analyses of neutravidin purified samples could be improved by biotinylating the 
Anl-containing proteins with a cleavable biotin probe. This would allow the samples to be eluted 
from the resin without resorting to the harsh conditions of boiling the resin in SDS sample buffer. 
This would simplify the elution samples, and proteins that non-specifically bound to the resin 
would likely not be eluted. Ngo and co-workers used a enrichment probe where the biotin moiety 
was separated from the clickable moiety via a disulfide bond. Reduction of the disulfide bond 
allowed for bound samples to be efficiently eluted 113.  
 
3.3.5 Analysis of immunopurified HA-tagged MetRSNLL 
For the final set of mass spectrometry experiments, I wanted to immunopurify a 
cytoplasmic T. gondii protein and send it for mass spectrometry analysis. Since cytoplasmic 
proteins are not sent through the secretory pathway, they do not have N-terminal signal peptides 
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to be removed. If Anl is only incorporated at the N-terminal position, it would still be present in 
these cytoplasmic proteins, so long as it was not removed by a aminopeptidase. The logical choice 
for a cytoplasmic protein to purify was the HA-tagged MetRSNLL, as I had already confirmed it 
could be successfully purified (Section 2.4.7). Since the protein is HA-tagged, I could be purified 
with a anti-HA antibody. The purified protein sample could be run on an SDS-PAGE gel, and the 
respective band excised from the gel for mass spectrometry analysis. 
For the immunopurifications, I infected HFFs with the Tg-MetRSNLL strain in either the 
presence or absence of Anl. After 2 days growth, the infected monolayers were washed to remove 
excess Anl and the parasites were isolated by needle passage and filtering with 5.0 µm syringe-
driven filters. The parasites were solubilized in TEN buffer (50 mM Tris (pH 8.0), 5 mM EDTA, 
150 mM NaCl) containing RIPA detergents (1% Triton-X100, 0.5% Deoxycholate, 0.01% SDS, 
and EDTA-free protease inhibitors). Insoluble material was removed by centrifugation, and the 
supernatant was used for immunopurification. The HA-tagged MetRSNLL was purified with an 
anti-HA monoclonal IgG1 antibody followed by incubation with Protein G Plus Agarose. After 
washing, the bound protein was removed by elution in either: 1) 0.1 M triethylamine (pH 11.5), or 
2) by boiling the resin in 100 µl of 1x SDS sample buffer. 
A western blot probing for the HA-tagged MetRSNLL confirmed that the purification was 
successful (Fig. 16A), though an analogous coomassie stained gel revealed that there were three 
prominent protein bands in the purification (Fig. 16B). The three distinct bands ran between 49-
80 kDa (Fig. 16B). The HA-tagged MetRSNLL is estimated to be 64 kDa, suggesting that the middle 
band is the one of interest. Regardless, each was sent for identification via mass spectrometry. For 
this purpose, the immunopurified samples were run on separate SDS-PAGE gels, one for the Anl 
treated samples (Fig. 16D) and one for non Anl treated samples (Fig. 16C), and each band was 
excised with a clean razor blade. The samples were run in duplicate, such that the excised bands 
could be sent to the Weiss laboratory for analysis and to Dr. Tatiana Laremore at the Proteomics 
and Mass Spectrometry Core Facility at The Huck Institutes of the Life Sciences, Pennsylvania 
State University.  
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 Figure 16. The HA-tagged MetRSNLL was immunopurified and sent for mass spectrometry analysis 
A) Western blot of the HA-tagged MetRSNLL from parasites of the Tg-MetRSNLL strain. HFFs were infected with the 
Tg-MetRSNLL strain at a MOI of 3 in the presence or absence of 1 mM Anl. After 2 days of growth, the parasites were 
isolated and solubilized in TEN buffer. The HA-tagged MetRSNLL was immunopurified with an anti-HA monoclonal 
antibody followed by incubation with Protein G resin, and eluted by boiling in SDS loading dye. The eluted samples 
were run on an SDS-PAGE gel alongside of “input” samples taken before the purification, and “unbound” samples of 
the protein which did not stick to the resin. The SDS-PAGE gel was transferred to nitrocellulose and probed with an 
anti-HA-HRP antibody. B) Coomassie stained version of a gel identical to the one used to prepare the western blot in 
A. Note: The brightness has been reduced by 30%, and contrast increased by 47% to make the bands more visible. C) 
Coomassie stained SDS-PAGE gel of the immunopurified HA-tagged MetRSNLL from the non Anl treated samples. 
Three protein bands were excised for mass spectrometry analysis. The samples were run in duplicate. Note: The 
brightness has been reduced by 30%, and contrast increased by 47% to make the bands more visible. D) An identical 
gel to the one from C, using the Anl treated samples instead. 
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With the samples sent to the Weiss laboratory, the HA-tagged MetRSNLL was identified 
amongst the peptide fragments, though the percent coverage of the protein was low, such that the 
N-terminal fragment was not identified. Some of the identified peptide fragments contained 
internal Met residues, though none of them had incorporated Anl. 
For the samples sent to Dr. Laremore, three T. gondii proteins were identified in both the 
Anl treated and non-treated samples: the HA-tagged MetRSNLL (64 kDa), elongation factor 1-alpha 
(49 kDa), and Calmodulin (16 kDa). Anl was not found in any of the three proteins. In the case of 
the non-treated sample, 4.62% of the HA-tagged MetRSNLL was represented by 2 unique peptides. 
Coverage was better for the Anl treated sample, with 55.95% coverage from 19 unique peptides 
(Fig. 17). None of the peptide fragments corresponding to the HA-tagged MetRSNLL were the N-
terminal fragment. As such, Anl could have been incorporated N-terminally, but it was missed 
because no N-terminal fragments were identified. The HA-tagged MetRSNLL contains 18 Met 
residues, including the N-terminal Met. Seven of the identified fragments had a Met residue. In 
order to assure that the N-terminal peptide fragment is identified, more concentrated samples are 
needed to increase the number of peptide fragments that are identified from the samples. 
 
Figure 17. The identified tryptic fragments of the HA-tagged MetRSNLL 
The sequence of the HA-tagged MetRSNLL with identified tryptic fragments highlighted in red, and surrounded by red 
boxes. Methionine residues are in bold. 
 
3.3.5.1 Additional HA-tagged MetRSNLL purifications 
Based on the incomplete coverage of the HA-tagged MetRSNLL from the first two mass 
spectrometry studies, I decided to prepare additional samples, increasing the amount of parasites 
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utilized. In the first set of HA purifications, each well in the SDS-PAGE gel contained 
approximately 5x106 parasites/well. In a new experiment, I doubled the number of T25s infected 
per strain, as a means to get a larger number of parasites to isolate the HA-tagged MetRSNLL. After 
isolating the parasites and doing the purification, the approximate number of parasites was 
3.05x106 parasites/well when run on an SDS-PAGE gel, a lower concentration than that from the 
first experiment. Despite this, I still excised bands and sent them to Dr. Laremore for analysis. 
Interestingly, when the immunopurified samples were run on the SDS-PAGE gel and coomassie 
stained for excision, there was only a single band present, as opposed to the three bands seen in 
the previous experiment. 
I sent Dr. Laremore six gel slices for analysis: two excised bands of the HA-tagged 
MetRSNLL from parasites grown in the presence of Anl, two excised bands of the HA-tagged 
MetRSNLL from parasites grown in the absence of Anl, and two excised bands of biotinylated HA-
tagged MetRSNLL. Biotinylating the Anl residues would change the mass of the Anl residue, 
increasing it by 553.32 mass units when compared to Met. 
In all of the excised bands, the major identified protein was bovine serum albumin (BSA), 
swamping out all of the other signals. The HA-tagged MetRSNLL was identified in most of the 
samples, but with a limited number of unique peptides (between 2 and 7), such that the percent 
coverage of the protein never rose above 17%. None of these fragments corresponded to the N-
terminal fragment, and none of them contained Anl, or biotin-conjugated Anl. Interestingly, a few 
other T. gondii proteins were represented by peptide fragments, including some rhoptry proteins 
(ROP5, 7, 8), a few heat shock proteins (HSP70, 90), and a putative elongation factor-1 alpha. 
The BSA contamination is peculiar, particularly since it was not a problem in the first set 
of immunopurified samples analyzed. The growth medium for HFFs is supplemented with fetal 
bovine serum, potentially explaining were it could have come from. Before isolating the parasites, 
the infected host cells were washed three times with PBS, before isolating the parasites and 
solubilizing them in TEN buffer. Dr. Laremore informed me that from her experience, BSA has a 
tendency to stick to resin. As such, any BSA remaining from the preparation of the parasites could 
have stuck to the resin, and ended up in the mass spectrometry analysis. 
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3.2.5 Conclusions 
The mass spectrometry studies that I conducted were designed to help determine what 
proteins incorporated Anl, and at what Met positions. Conclusive answers were not drawn for any 
of those queries. The mass spectrometry data collected by the Weiss laboratory from purified 
parasite samples suggested that Anl was incorporated at internal Met positions in both host and 
parasite proteins, but only at a very low level. The percent incorporation was low enough to call 
into question the accuracy of the peptide assignments. Additional mass spectrometry studies will 
need to be performed in order to determine what proteins can incorporate Anl. Performing all of 
the parasite preparations on a larger scale would supply higher protein concentrations at the onset 
of the mass spectrometry experiments, hopefully leading to better protein coverage. Different 
subcellular fractions could be isolated from Anl treated parasites (membrane fraction 134, rhoptry 
fraction 138, etc.) to have a more focused screen for the incorporation of Anl into a particular set of 
proteins. 
Specifically immunopurifying the HA-tagged MetRSNLL from Anl treated parasites was 
used to determine what Met residues could incorporate Anl. However, percent coverage was not 
high enough to identify an N-terminal peptide from the protein. Immunopurifications should be 
performed on additional parasite proteins that are not thought to be processed. A good candidate 
would be the click beetle luciferase that is expressed in the Tg-MetRSNLL strain, which the lab 
already has antibodies against. More vigorous washes should be performed to minimize BSA 
contamination issues. Furthermore, the HFFs could be grown in a minimal growth medium, not 
supplemented with fetal bovine serum.  
3.3 MUTATING T. GONDII METRS TO CHARGE TRNAMET WITH ANL 
Mutating the T. gondii MetRS gene to encode a version of the enzyme that can accept Anl, 
and charge it to both T. gondii tRNAMet, might allow Anl to be readily incorporated in parasite 
proteins. This would replace the need to employ the bacterial MetRSNLL in T. gondii, and would 
foreseeably result in an increase in the number of parasite proteins that are Anl-labeled. To 
recognize Anl, the bacterial MetRS has three amino acid changes in the methionine binding pocket 
of the enzyme (L13N, Y260L and H301L; hence the name MetRSNLL) 100. These three mutated 
residues are conserved in methionine tRNA synthetases from bacteria to humans 101. In fact, the 
Met binding pocket of the enzyme is one of the few portions of the enzyme that is well conserved, 
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as assessed by mapping conservation to the crystal structure of the E. coli enzyme (Fig. 18). In T. 
gondii, the three amino acids correspond to I284, Y507, and H537. The first of the three residues 
is isoleucine (Ile) in T. gondii, as opposed to leucine (Leu) like most other organisms examined. 
Since Ile and Leu are both similarly sized, hydrophobic amino acids, the change is not likely to 
cause a functional change. Mutating these three residues to correspond to the mutations in the 
bacterial MetRSNLL may allow the T. gondii protein to charge Anl onto both T. gondii tRNAMet.  
 
Figure 18. E. coli MetRS crystal structure with sequence conservation of MetRS mapped to the surface 
The sequence conservation of MetRS was mapped to the surface representation of the crystal structure of the enzyme 
from E. coli. 
 
3.3.1 Amplifying the T. gondii MetRS gene 
The coding sequence of T. gondii MetRS was amplified from cDNA using primers which 
added attB1 and attB2 sites on either side of the gene (Table 2) to be inserted into the Gateway 
pDONR221 vector (Life Technologies, Carlsbad, CA) by a BP Clonase II reaction. This was 
prepared simply as a means to have a version of the unmutated T. gondii MetRS gene in a bacterial 
vector (pDONR-TgMetRS) to use as a template for future amplification reactions, as opposed to 
resorting to using cDNA.  
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Table 2. Primers used for mutating the T. gondii MetRS and for amplifying the mutant murine MetRS 
Primer name Sequence 
(5’-3’) 
Purpose 
For_MetRS_B1 GGGGACAAGTTT
GTACAAAAAAGC
AGGCTCTTTCTG
CCGTTCTGGATT
GC 
Forward primer for amplifying the 
TgMetRS gene. Adds attB1 site for 
cloning into pDONR221 vector via a BP 
Clonase II reaction. 
Rev_MetRS_B2 GGGGACCACTTT
GTACAAGAAAGC
TGGGTCTTGTCG
TCCTGACATCTC
CC 
Reverse primer for amplifying the 
TgMetRS gene. Adds attB2 site for 
cloning into pDONR221 vector via a BP 
Clonase II reaction. 
For_A_TgMetRS_SbfI GCTACCTGCAGG
TCCACAATGACC
GGCTCTTCTCC 
Forward primer for Fragment A of 
TgMetRS. Not properly in frame of 
promoter in pGra-HA-HPT. Do not use. 
New_For_A_TgMetRS_SbfI GCTACCTGCAGG
gaTCCACAATGA
CCGGCTCTTCTC
C 
New forward primer for Fragment A of 
TgMetRS. Has a SbfI restriction site. 
Properly in frame of promoter in pGra-
HA-HPT.  
Rev_A_TgMetRS CGTGTAGTTGTT
GGCCGTGG 
Reverse primer for Fragment A of 
TgMetRS. Introduces T851A nucleotide 
change. Results in I284N substitution 
in translated protein. 
For_B_TgMetRS CCACGGCCAACA
ACTACACG 
Forward primer for Fragment B of 
TgMetRS. Introduces T851A nucleotide 
change. Results in I284N substitution 
in translated protein. 
Rev_B_TgMetRS CCGTTGCTGAGT
AGAGGTTGG 
Reverse primer for Fragment B of 
TgMetRS. Introduces T1519C, A1520T 
nucleotide changes. Results in Y507L 
substitution in translated protein. 
For_C_TgMetRS CCAACCTCTACT
CAGCAACGG 
Forward primer for Fragment C of 
TgMetRS. Introduces T1519C, A1520T 
nucleotide changes. Results in Y507L 
substitution in translated protein. 
Rev_C_TgMetRS GCCAAATCACCG
TGAGAAACC 
Reverse primer for Fragment C of 
TgMetRS. Introduces A1610T nucleotide 
change. Results in H537L substitution 
in translated protein. 
For_D_TgMetRS GGTTTCTCACGG
TGATTTGGC 
 
Forward primer for Fragment D of 
TgMetRS. Introduces A1610T nucleotide 
change. Results in H537L substitution 
in translated protein. 
Rev_D_TgMetRS_SbfI GCTACCTGCAGG
AAGCGCGAGAGA
AAGGCG 
Reverse primer for Fragment D of 
TgMetRS. Has a SbfI restriction site. 
Do not use. This adds the same 
restriction site as the forward primer 
for Fragment A. A new restriction site 
is needed.   
Rev_D_TgMetRS_BspHI GCTATCATGAAA
GCGCGAGAGAAA
GGCG 
Reverse primer for Fragment D of 
TgMetRS. Has a BspHI restriction site. 
Properly in frame of HA tag in pGra-
HA-HPT.   
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For_TgMetRS_Q5 CCTTGACCAACC
TCTACTCAGCAA
CG 
First of two primers for introducing 
the T1519C, A1520T nucleotide changes 
to the TgMetRS gene via Q5 site-
directed mutagenesis. 
Rev_TgMetRS_Q5 CATCGAACCAGA
CGTACATGACAT
G 
Second of two primers for introducing 
the T1519C, A1520T nucleotide changes 
to the TgMetRS gene via Q5 site-
directed mutagenesis. 
For_mMetRSg_SbfI GCTACCTGCAGG
GAAGACTGTTCG
TGAGCGAG 
Forward primer for amplifying the 
mutated murine MetRS (mMetRSG) gene 
from a vector provided by the Tirell 
lab. Has a SbfI restriction site. 
Properly in frame of promoter in pGra-
HA-HPT. 
Rev_mMetRSg_BspHI GCTATCATGACT
TTTTCTTCTTGC
CTTTAGGA 
Reverse primer for amplifying the 
mutated murine MetRS (mMetRSG) gene 
from a vector provided by the Tirell 
lab. Has a BspHI restriction site. 
Properly in frame of HA tag in pGra-
HA-HPT.   
 
3.3.2 Introducing nucleotide changes into the T. gondii MetRS gene 
Before devising the nucleotide changes that needed to be introduced for the appropriate 
amino acid substitutions (I284N, Y507L, H537L), I looked into the literature to determine which 
codon for each of the substituted amino acids was most commonly utilized in T. gondii 139. I found 
that CTC was the most commonly used codon for leucine (L), and that AAC was most common 
for asparagine (N). For I284N, only a single nucleotide change was needed (T851A). For Y507L, 
two nucleotide changes were needed (T1519C, A1520T). And for H537L, only a single nucleotide 
change was needed (A1610T). 
Originally, I planned to use Splicing by overhang extension (SOE) PCR to introduce all 
four of the nucleotide changes. This utilized four pairs of primers to create overlapping fragments 
of the gene, designated fragment A through D, which could be combined via SOE PCR (Fig. 19). 
Successfully amplifying and purifying fragment C proved difficult due to its small size. To get 
around this, I used the B forward primer and the C reverse primer (Table 2) to create a larger BC 
fragment. Doing this bypassed two of the nucleotide changes (T1519C, A1520T), however. 
Fragments A, BC, and D were successfully combined using SOE PCR, creating a version of the 
T. gondii MetRS gene with two of the mutations (T851A, and A1610T). This was inserted into the 
pGra-HA-HPT expression plasmid 140, in frame of a C-terminal HA tag and a highly active T. 
gondii promoter (GRA1 141). The final two nucleotide changes (T1519C, A1520T) were 
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introduced using New England Biolab’s Q5 site-directed mutagenesis kit and two specially 
designed primers (Table 2). After two attempts to transfect the expression vector (pGra-HA-HPT-
TgMetRSNLL) into T. gondii and being unable to detect any HA-tagged protein in the transfected 
populations, I discovered that the gene was not properly in frame of the dense granule promoter in 
the pGra-HA-HPT expression vector. I designed a new forward primer 
(New_For_A_TgMetRS_SbfI, Table 2) to amplify the mutated gene out of the current pGra-HA-
HPT-TgMetRSNLL vector, which should correct the problem when inserted into pGra-HA-HPT. 
 
Figure 19. Engineering four nucleotide changes into T. gondii’s MetRS gene may allow the enzyme charge Met 
tRNA with Anl 
Four nucleotide changes (T851A, T1519C, A1520T, and A1610T) were engineered into T. gondii’s MetRS gene. SOE 
PCR was used to generate four gene fragments (A though D) and then combine them. Each fragment is delineated by 
a colored box. The specific nucleotides that were mutated from their original residues are highlighted in yellow. The 
binding sites for the primers used to generate the fragments are highlighted in grey. 
Once the new pGra-HA-HPT-TgMetRSNLL vector is prepared, inserting it into parasites 
will be a relatively simple task, as T. gondii is a very genetically tractable organism. The mutated 
TgMetRSNLL’s ability to charge tRNAMet with Anl can be tested on the transfected parasite 
population, before isolating stable clones. The transfected population can be grown in the presence 
of Anl and the parasites can be solubilized and biotinylated with click chemistry. The presence of 
biotinylated proteins on a western blot would provide evidence that the TgMetRSNLL was 
functional. 
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3.4 EXPRESSING A MUTATED MURINE METRS IN T. GONDII, CAPABLE OF 
CHARGING ANL TO BOTH EUKARYOTIC TRNAMET 
In February (2015), David Tirell, who first developed the MetRSNLL/Anl system,  sent us 
an expression vector with a mutated version of the murine MetRS which, when expressed in 
mammalian cells, resulted in the incorporation of Anl at internal Met residues. While these data 
are as yet unpublished, a publication is forthcoming.  
Interestingly, there is only one amino acid substitution in the protein. The substitution is a 
leucine to a glycine in the Met binding site of the enzyme. It happens to correspond to the same 
active site leucine that was mutated in the E. coli MetRS to permit the binding of Anl. The lack of 
a functional group on glycine likely provides additional space in the Met binding site of the 
enzyme, allowing the bulkier Anl to fit inside. 
I have designed primers to amplify the mutant murine MetRS (mMetRSG) out if the 
mammalian expression vector, adding restriction sites for inserting it into the pGra-HA-HPT T. 
gondii expression vector. Once the gene is inserted into the pGra-HA-HPT expression vector, it 
can be transfected into parasites. Since the bacterial MetRSNLL is functional in T. gondii, it seems 
very likely that the MetRS from a fellow eukaryotic organism would be functional.  
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4.0 CONCLUSIONS AND FUTURE DIRECTIONS 
My time in the Boyle laboratory has largely been spent designing a system for specifically 
labeling T. gondii proteins while the parasite grows inside of a host cell. Developing such a system 
could have a profound impact on better understanding how T. gondii interacts with the host cell to 
permit its survival. Initially, the project was formulated as a means to better characterize the cohort 
of proteins that the parasite secretes into the host cell during the invasion process. A pioneering 
study attempting to identify the components of the T. gondii secretome utilized a 1% ethanol 
solution to artificially trigger secretion in vitro 142. While the approach is a powerful one, it does 
not allow the study of secretion in the more natural environment of the host cell. Most conventional 
strategies for the metabolic labeling of proteins utilize radiolabeled amino acids or, more recently, 
the incorporation of reactive nonstandard amino acids which can be modified for identification or 
purification 90. When studying a system that involves two cell types, like T. gondii infecting a host 
cell, these methods result in the labeling of both cell types. To circumvent this problem, I 
developed a strain of T. gondii that expresses a mutated form of E. coli methionyl-tRNA synthetase 
(MetRSNLL) that permits a methionine analog, azidonorleucine (Anl), to be charged to tRNAMet, 
and subsequently incorporated into nascent proteins 86. The azide functional group on Anl allows 
proteins which have incorporated the analog to be tagged fluorescently or with a affinity tag by a 
copper-catalyzed “click” chemistry reaction 87. 
The majority of my efforts in the Boyle laboratory have been spent characterizing the 
MetRSNLL/Anl labeling system in T. gondii. The bacterial MetRSNLL is successfully expressed in 
T. gondii, and is functional, allowing for the incorporation of Anl into a plethora of proteins. The 
incorporation of Anl is limited to the T. gondii strain that expresses the mutant MetRS (the Tg-
MetRSNLL strain). Prolonged growth in the presence of Anl reduces parasite numbers of the Tg-
MetRSNLL strain, but does not affect that of a WT T. gondii strain. Despite this, the Anl treated 
parasites are able to successfully mount new host cell invasions, suggesting that Anl incorporation 
does not have an overly deleterious effect on the parasites. Most applications of the MetRSNLL/Anl 
labeling system would only require short pulses of Anl, such that prolonged growth in Anl would 
not be necessary. 
While a large number of parasite proteins appear to incorporate Anl, secreted parasite 
proteins look to only be minimally labeled. This may be due to an incompatibility between the 
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bacterial MetRSNLL and the two T. gondii tRNAMet 113. Early work examining the ability of a 
bacterial MetRS to substitute for its eukaryotic counterpart found that it could only append Met to 
the eukaryotic initiator tRNAMet, and not the elongator tRNAMet 120-123. If this is the case with the 
E. coli MetRSNLL being expressed in T. gondii, then only the initiator tRNAMet could be charged 
with Anl, permitting only the N-terminal Met residue to be replaced with Anl. Since most proteins 
that travel through the secretory pathway have their N-terminus processed, those proteins would 
no longer maintain the Anl label. Indeed, when Ngo and coworkers tried expressing the bacterial 
MetRSNLL in mammalian cells, they found that Anl was only found at the N-terminus and that N-
terminally processed proteins were not labeled 113. 
To help determine whether the incorporation of Anl was confined solely to the N-terminus, 
or whether it could replace internal Met residues, I collaborated with a number of laboratories on 
mass spectrometry studies. The majority of these studies proved to be inconclusive, though one 
conducted with Dr. Louis Weiss’ laboratory implied that Anl could be incorporated at internal Met 
positions in both parasite and human proteins. The percentage of proteins incorporating Anl was 
extremely low, casting doubt on whether the peptide assignments were legitimate. Mass 
spectrometry studies on the immunopurified HA-tagged MetRSNLL did not reveal that it 
incorporated Anl, though percent coverage of the protein by identified peptides never rose above 
50%. Furthermore, the N-terminal fragment was never identified. 
In order for the project to move forward, more mass spectrometry studies will be needed 
to concretely determine what Met residues can incorporate Anl. Doing analyses on solubilized 
parasite samples is not the ideal means to get at the question, as the complexity of the samples 
prevents obtaining a large number of reads from any particular protein. If the incorporation of the 
analog is infrequent, and all of the present mass spectrometry studies suggest that it is, more 
inclusive coverage of individual proteins is what is needed. For this reason, immunopurifying 
specific proteins from Anl treated parasites and individually subjecting them to mass spectrometry 
analysis will be essential. Despite not have good luck with the experiments with the HA-tagged 
MetRSNLL, I still think that it is a good choice. The protein is cytoplasmic, so it should not be N-
terminally processed, leaving the N-terminus intact in case that is the only Met residue capable of 
being replaced by Anl. It should be noted that this residue could still be removed by methionine 
aminopeptidases. The HA-tagged MetRSNLL has an additional 17 Met residues beyond the 
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initiating Met, which is a sizeable number for a 563 amino acid protein. Another potential 
candidate for immunopurification is the click beetle luciferase that is expressed by the parasite. 
Like the HA-tagged MetRSNLL, it is an ectopically expressed protein, but it is cytoplasmic and the 
laboratory already has an antibody against it. 
If the MetRSNLL/Anl labeling system in its present format cannot label proteins which are 
N-terminally processed, then it will not be useful for comprehensively characterizing the T. gondii 
secretome. Though, it could identify those secreted proteins that are not N-terminally processed. 
Indeed, not all proteins that migrate through the secretory pathway are N-terminally processed.  
Membrane bound proteins with signal anchor sequences do not have signal peptides, and are 
guided to the membrane by the hydrophobic alpha helical signal anchor.  
The most promising means to move the project forward involve creating new parasite 
strains with a mutated eukaryotic version of the MetRS. Mutating T. gondii’s MetRS to recognize 
Anl and charge it to tRNAMet would likely ensure that Anl is incorporated at all Met residues. The 
high level of conservation of the Met binding site in MetRS suggests that mutating the same three 
residues from the E. coli MetRS in the T. gondii enzyme might permit it to bind Anl 101. Even if 
that is unsuccessful, expressing the recently acquired mutated murine MetRSG in T. gondii might 
also allow more complete incorporation of Anl into T. gondii proteins. If a bacterial MetRS was 
functional in T. gondii, the MetRS from a fellow eukaryotic organism will doubtlessly be 
functional, as well. Since the incorporation of Anl results in a reduction of parasite numbers after 
prolonged Anl exposure, the possibility exists that when Anl is more widely incorporated into T. 
gondii proteins, there could be more profound effects. If this is the case, adjusting the concentration 
of Anl used in the labeling studies might remedy the problem.  
While some additional work is still needed to fully characterize the MetRSNLL/Anl labeling 
system in T. gondii, it is poised to make a significant impact our understanding of host/pathogen 
interaction. Furthermore, in its present form, the system should also be functional in other 
Apicomplexan parasites, including Plasmodium spp. If any of the modifications of the system 
prove effective at increasing the levels of Anl-incorporation in parasite proteins, those 
modifications should be readily applicable to other parasite systems, as well. 
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5.0 MATERIALS AND METHODS 
5.1 HOST CELL CULTURE 
All assays were performed in human foreskin fibroblasts (HFFs), which were grown in DMEM 
supplemented with 10% fetal bovine serum, 2 mM glutamine (Life Technologies, Rockville, MD), 
50 μg/mL each of penicillin (Life Technologies, Rockville, MD) and streptomycin (Life 
Technologies, Rockville, MD). The cells were maintained at 37°C in 5% CO2. 
5.2 EXPRESSION OF E. COLI METRSNLL IN T. GONDII 
The E. coli MetRSNLL gene used for creating the MetRSNLL-expressing T. gondii strain (the Tg-
MetRSNLL strain) was cloned into the pQE-80L bacterial expression vector. The version of the 
MetRS gene housed within the vector encodes a truncated form of the protein, shortened from 677 
amino acids to 548. The missing C-terminal amino acids have a role in MetRS dimerization, 
though their absence should have minimal effects on successful incorporation of Anl into proteins, 
as monomeric MetRS is functionally indistinguishable from the native dimeric form 143. The gene 
was PCR amplified from the vector using primers with unique restriction sites (Forward Primer, 
NsiI site underlined: gttaatgcatcctactatgactcaagtcgcga; Reverse Primer, NcoI site underlined: 
gctaccatggtttagaggcttccagtgcttcaacc). Using the added restriction sites, the PCR product was 
cloned into the pGra-HA-HPT expression plasmid 140, in frame with a C-terminal HA tag and 
under the control of a highly active dense granule protein promoter (GRA1 141). The pGra-HA-
HPT vector includes the parasite hypoxanthine-xanthine-guanine phosphoribosyl transferase 
(HPT) gene which is used to select for stable incorporation of the vector into the genome of a 
ΔHPT T. gondii strain when grown in the presence of mycophenolic acid (MPA) and xanthine 
144,145. The pGra-HA-HPT-MetRSNLL vector was transfected into the type II parasite strain 
Me49ΔHPT:Luc and successful transformants were selected for using MPA (25 μg/ml; Sigma-
Aldrich, St. Louis, MO) and xanthine (50 μg/ml; Sigma-Aldrich, St. Louis, MO) 144,145. Drug 
resistant clones were obtained by limiting dilution in 96-well plates. A MetRSNLL-expressing strain 
(the Tg-MetRSNLL strain) was generated with this process, along with a MPA-resistant strain which 
lacked the MetRSNLL gene. This strain served as a wild type control for the experiments, as it was 
prepared under the same conditions but does not express the MetRSNLL. 
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5.3 WESTERN BLOT ANALYSIS 
To probe for expression of the HA-tagged MetRSNLL, HFFs infected with either WT T. gondii or 
the Tg-MetRSNLL strain were lysed in 1x sodium dodecyl sulfate (SDS) sample buffer and resolved 
on 8% SDS-polyacrylamide gels. The samples were transferred to nitrocellulose membrane (Bio-
Rad, Hercules, CA). After the transfer, the membranes were blocked in Tris-buffered saline (TBS) 
with 0.05% Tween 20 (TBST) and 5% Bovine serum albumin (BSA; Sigma-Aldrich, St. Louis, 
MO) or 5% non-fat dry milk for 1 h. After blocking, the membrane was incubated in anti-HA-
peroxidase (Roche, Mannheim, Germany) antibody at a 1:4000 dilution for 30 m. After incubation, 
the blot was washed 3 times with TBST and developed using SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Scientific, Rockford, IL). To test for equal loading, the blot 
was stripped with Restore Western Blot Stripping Buffer (Thermo Scientific, Rockford, IL), and 
reprobed with Mouse anti-TgSAG1 (GenWay) at a 1:4000 dilution for 1 h. After three washes 
with TBST, the blot was incubated with Goat anti-mouse IgG-HRP (Santa Cruz Biotechnology, 
Santa Cruz, CA) at a 1:4000 dilution for 1 h. After washing the blot 3 times with TBST, it was 
developed using SuperSignal West Pico Chemiluminescent Substrate. 
5.4 INCORPORATION OF AZIDONORLEUCINE (ANL) INTO PARASITES 
A confluent monolayer of HFFs in a T25 culture flask was infected with either WT T. gondii or 
the Tg-MetRSNLL strain at a multiplicity of infection (MOI) of 3, and supplemented with 1 mM 
Anl (from a 100 mM stock in H20). In some instances, the medium was supplemented with 
additional Anl 24 h after initial infection. After 48 h of growth, the infected monolayer of HFFs 
was washed with Phosphate Buffered Saline (PBS; Fischer Scientific, Pittsburgh, PA) and scraped 
from the T25 culture flask in 3 ml of PBS. The infected HFFs were centrifuged at 800xg for 10 m, 
and solubilized in 100 µl of 2% SDS in PBS, followed by boiling for 5 m. The samples were 
diluted to 0.5% SDS with PBS including cOmplete EDTA-free protease inhibitors (Roche 
Diagnostics; Indianapolis, IN).  
5.5 CLICK CYCLOADDITION REACTION 
Cycloaddition reactions were performed on the cell lysates in a final volume of 50 μl of 50 μM 
biotin-alkyne (Invitrogen Molecular Probes, Eugene, OR) or 10 µM Alexa Fluor 594-alkyne 
(Invitrogen Molecular Probes, Eugene, OR), along with 1 mM tris(2-carboxyethyl)phosphine 
(TCEP; Sigma-Aldrich, St. Louis, MO), 100 mM tris-(benzyltriazolylmethyl)amine ligand 
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(TBTA; Sigma-Aldrich, St. Louis, MO), and 1 mM copper(II) sulfate (CuSO4; Sigma-Aldrich, St. 
Louis, MO). This mixture was incubated at room temperature for 2 h with rotation 104,105. When 
using Alexa Fluor 594-alkyne, samples were obscured from light during the incubation. Samples 
were used directly for SDS-PAGE analysis or neutravidin purification. 
5.6 DETERMINING THE OPTIMAL ANL CONCENTRATION FOR EFFICIENT 
INCORPORATION INTO NASCENT PROTEINS 
HFFs were infected with the Tg-MetRSNLL strain and the growth medium was supplemented with 
varying concentrations of Anl (0.1 mM, 0.5 mM, 1.0 mM, or 4.0 mM) at the time of infection. 
After 48 h of growth, the infected monolayer was washed to remove excess Anl and the infected 
HFFs were solubilized in 2% SDS/PBS and diluted to 0.5% SDS to facilitate click chemistry. The 
samples were biotinylated with click chemistry using biotin-alkyne and analyzed via western blot, 
probing with streptavidin-HRP. 
5.7 LUCIFERASE GROWTH ASSAYS 
WT T. gondii and the Tg-MetRSNLL strain were derived from the same parental parasite line, which 
expresses a soluble form of firefly luciferase.  To determine the effects of Anl on parasite growth, 
10000 parasites were used to infect confluent HFF monolayers in a 96-well plate in triplicate.  
Cells were exposed to either 1 mM Anl or vehicle (water) 16 h post-infection, and processed for 
bioluminescence at 24, 48 and 72 h post-Anl exposure.  Cells were lysed using 1X luciferase lysis 
buffer (Promega, Madison, WI) and frozen at -80°C until analysis.  Twenty µL of each sample 
was added to a Greiner Cellstar® 96-well plate with an opaque bottom, and 50 µL of luciferase 
assay reagent (Promega, Madison, WI) was added to each well immediately prior to analysis on a 
Centro XS3 LB 960 microplate luminometer.  Luminescence was measured for 10 s in each well 
with no delay between each.  For each strain (WT T. gondii, the Tg-MetRSNLL strain) data were 
converted to percent of control by dividing the signal in the presence of Anl by the signal in its 
absence.   
5.8 NEUTRAVIDIN PURIFICATION 
A confluent monolayer of HFFs in a T25 culture flask was infected with either WT T. gondii or 
the Tg-MetRSNLL strain at MOI 3, and supplemented with 1 mM Anl . After 48 h of growth, the 
infected monolayers were washed 3 times with PBS to remove unincorporated Anl. The 
monolayers were scraped from their culture flasks, and syringe lysed by passage through 25 gauge 
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(g) and 27g needles in 3 ml of PBS including cOmplete EDTA-free protease inhibitors (Roche 
Diagnostics; Indianapolis, IN). The samples were centrifuged at 800xg for 10 m, and solubilized 
in 100 µl of 2% SDS in PBS, followed by boiling for 5 m. The samples were diluted to 0.5% SDS 
with PBS including cOmplete EDTA-free protease inhibitors (Roche Diagnostics; Indianapolis, 
IN). The samples were subjected to click chemistry with biotin-alkyne. Half of the sample was 
saved as an input and the rest was used for neutravidin purification. 200 μl of well-mixed 
neutravidin agarose resin (Thermo Scientific, Rockford, IL) was used for each purification, and 
was equilibrated according to manufacturer’s instructions. The samples were incubated with the 
equilibrated resin for 2 h at room temperature with rotation. After incubation, the samples were 
centrifuged at 2500xg for 1 m and the supernatant was saved as an “unbound” sample. The resin 
was washed 3 times with PBS, one time with PBS with 0.2% SDS, and a final time with PBS. The 
bound samples were eluted by boiling for 5 m in 200 μl of 1x SDS sample buffer. The eluted 
samples were then used directly for SDS-PAGE analysis followed by western blotting. The mouse 
monoclonal anti-ROP7 1B10 antibody was generously provided by Peter Bradley (University of 
California, Los Angeles; 146), and used at a 1:1000 dilution. The rabbit anti-Rop5 antibody 147 and 
rabbit anti-Rop18 antibody 148 were generously provided by David Sibley (Washington University 
School of Medicine). 
5.9 IN SITU LABELING OF PARASITES USING CLICK CHEMISTRY 
A confluent monolayer of HFFs in a T25 culture flask was infected with either WT T. gondii or 
the Tg-MetRSNLL strain at MOI 3, and supplemented with 1 mM Anl. After 48 h of growth, the 
infected monolayers were washed 2 times with PBS to remove unincorporated Anl. The 
monolayers were scraped from their culture flasks, and syringe lysed by passage through 25g and 
27g needles. The Anl treated parasites were then used to infect HFF-seeded coverslips at MOI5 
for 6 h. The cells were washed once with PBS and then were fixed for 20 m at room temperature 
in 4% electron microscopy grade paraformaldehyde (prepared from 16% stock). The coverslips 
were washed twice with PBS, and then blocked with PBS supplemented 5% BSA and 0.1% Triton 
X‐100 for 1 h. After fixation and blocking, a click reaction was performed on the samples using 
Alexa Fluor 594-alkyne for 1 h. The coverslips were washed 2 times with PBS to remove excess 
Alexa Fluor 594-alkyne. Additionally, the coverslips were incubated with anti-Gra7 monoclonal 
mouse antibody at a dilution of 1:2000 for 1 h, washed 3 times with PBS, and incubated with Alexa 
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Fluor 488 Goat Anti-Mouse IgG at a dilution of 1:2000 for 1 h. After 3 PBS washes, the coverslips 
were mounted with Vectashield (Vector Laboratories, Burlingame, CA). The monoclonal antibody 
to Gra7 was generously provided by Peter Bradley (University of California, Los Angeles; 146). 
5.10 SAMPLE PREPARATION FOR MASS SPECTROMETRY 
Human foreskin fibroblasts (HFFs) were infected with either WT T. gondii or the Tg-MetRSNLL 
strain at a MOI of 3 in the presence of 1 mM Anl. 8 to 15 T25 culture flasks of HFFs were infected 
per strain. After 2 days of growth, the infected host cells were washed two times with 4 ml of PBS 
to remove unincorporated Anl. Sample preparation diverges at this point, depending on whether 
1) infected host cell lysates were required, or 2) purified parasite samples are required. 
5.10.1 Infected host cell lysates 
After washing the infected HFFs with PBS, they were combined in 1 ml of RIPA buffer prepared 
from Sigma-Aldrich’s Mammalian Cell lysis kit. The samples were incubated at room temperature 
for 15 minutes with shaking before being centrifuged at either 12,000xg for 10 minutes, or 
100,000xg for 45 minutes, to pellet the cellular debris. The supernatant was frozen and sent for 
mass spectrometry analysis 
5.10.2 Purified parasites 
After washing the infected HFFs with PBS, the parasites were isolated by passage through 25g 
and 27g needles in 3 ml of PBS. The lysatse were passed through 5.0 µm syringe-driven filters to 
remove cell debris, followed by centrifugation at 800xg to pellet the parasites. The pelleted 
parasites were resuspended in 300 µl of RIPA buffer and incubated with shaking at room 
temperature for 15 minutes, before centrifugation at 12,000xg to pellet insoluble material. The 
supernatant was frozen and sent for mass spectrometry analysis. 
5.11 IMMUNOPURIFICATION OF HA-TAGGED METRSNLL 
To prepare samples for the immunopurification of the HA-tagged MetRSNLL, 10-15 T25s were 
infected with the Tg-MetRSNLL strain at a MOI of 3. 1 mM Anl was added to the growth medium 
of half of the T25 culture flasks of infected HFFs, the others served as no treatment controls. After 
48 hours of growth, the infected monolayers were washed twice with 3 ml of PBS. The infected 
HFFs were removed from the culture flasks with cell scrapers, and combined in a total of 3 ml of 
PBS, with separate samples based on Anl treatment. Parasites were released from the HFFs by 
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passing the combined samples through 25g and 27g needles, and host cell debris was removed 
with a 5 μm syringe-driven filter. After counting parasites, the samples were centrifuged at 800xg 
for 10 minutes to pellet the parasites. The pelleted parasites were resuspended in 1 ml of TEN 
buffer (50 mM Tris (pH 8.0), 5 mM EDTA, 150 mM NaCl) containing RIPA detergents (1% 
Triton-X100, 0.5% Deoxycholate, 0.01% SDS, and cOmplete EDTA-free protease inhibitors 
(Roche Diagnostics; Indianapolis, IN)). The mixture was incubated on ice for 30 minutes before 
centrifugation at 3,000xg for 20 minutes to remove any insoluble material. The supernatant was 
saved as the sample to be used for immunopurification. 500ul of the sample was saved as an input, 
and the remainder was incubated with a 1/1000 dilution of anti-HA (clone 3F10) monoclonal rat 
IgG1 antibody (Roche, Mannheim, Germany) for 4 hours at 8oC with gentle agitation. After 
incubation with the anti-HA antibody, the sample was added to 50 µl of Pierce Protein G Plus 
Agarose (Life Technologies, Carlsbad, CA) which was equilibrated according to the 
manufacturer’s protocol. The samples were incubated with rotation at 4oC for 2 hours, before being 
centrifuged at 800 xg for 1 minute. The supernatant was saved as an “unbound” sample. The resin 
was washed three times with 500 µl of TEN buffer before elution. The bound samples were eluted 
in one of two ways, 1) with 0.1 M triethylamine (pH 11.5), or 2) by boiling the resin in 100 µl of 
1x SDS sample buffer. For the 0.1 M trimethylamine elution, there were five successive elutions 
which were combined. For each elution, 50 μL of 0.1 M trimethylamine was added to the resin 
and incubated with gentle agitation at room temperature for 5 minutes. The resin was centrifuged 
at 800xg for 1 minute and the supernatant was carefully removed as the elution. The 
trimethylamine was neutralized by adding an equal volume of 1.0M Tris, pH 6.8. The five 
neutralized elutions were combined, and concentrated by TCA precipitation. The immunopurified 
samples were run on SDS-PAGE gels and coomassie stained. Bands were excised with clean razor 
blades and sent for mass spectrometry analysis. 
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APPENDIX A THE ROP16 ORTHOLOG IN HAMMONDIA HAMMONDI IS 
FUNCTIONAL IN T. GONDII  
I worked briefly on a project looking at orthologs of T. gondii effector proteins in 
Hammondia hammondi, T. gondii’s closest extant relative 149,150. Since H. hammondi is not able 
to be grown in cell culture, we have heterologously expressed the orthologs in T. gondii and looked 
for phenotypic changes. In particular, I was working with secreted rhoptry kinase, Rop16, which 
is known to phosphorylate and activate members of the signal transducer and activator of 
transcription (STAT) signaling pathway, namely STAT3 and STAT6 151. The various differing 
strains of T. gondii are known to differ in their ability to activate STAT3/6. There are three 
predominant strain types (I, II, and III), with Types I and III being able to activate STAT3/6, and 
Type II strains are unable to do so 140. When expressing H. hammondi’s Rop16 (HhRop16) in a 
type II strain of T. gondii (T. gondii Type II:HhRop16), there was an increase in the levels of 
phosphorylated Stat6 in the host nucleus 152.  
Since the T. gondii Type II:HhRop16 still has its endogenous copy of the Rop16 
(TgRop16II), there is a possibility that the increase in phosphorylated Stat6 is due to dosage effects. 
In order to investigate this possibility, I created a Type II T. gondii clone which expressed a second 
copy of TgRop16II, driven by the same promoter as the HhRop16 (T. gondii Type II:TgRop16II). 
I compared how this strain activated Stat6 in infected host cells to WT Type II T. gondii and T. 
gondii Type II:HhRop16. I found that both the WT Type II T. gondii and T. gondii Type 
II:TgRop16II were similar in their inability to activate Stat6, but T. gondii Type II:HhRop16 
significantly increased levels of activated Stat6 (Fig. 19). This supports the notion that H. 
hammondi has a functional ortholog of Rop16. 
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 Figure 20. The H. hammondi ortholog of ROP16 increases levels of pSTAT6 in the host cell nucleus 
HFFs were infected with either WT Type II T. gondii, Type II T. gondii expressing a second copy of TgRop16II, or 
Type II T. gondii expressing HhRop16. Phosphorylated Stat6 levels in the nuclei of HFFs was examined by 
immunofluorescence, subtracting cytoplasmic fluorescent signal from nuclear fuorescent signal. At least 16 randomly 
selected infected HFFs were chosen per strain. **,  P <0.001 compared to WT Type II T. gondii. Note: The image 
used in this figure is a slightly modified version of that which appears in the published version of the work 152. 
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APPENDIX B MITOCHONDRIAL STUDIES USING THE SEAHORSE ANALYZER 
I began a collaborative project with Dr. Bennett Van Houten investigating the effect that 
T. gondii infection has on host cell mitochondria using a Seahorse XFe Mitochondrial Analyzer. 
The parasitophrous vacuole of some strains of T. gondii is known to associate host mitochondria 
upon invasion, though the biological significance for this association is not presently known. A 
Seahorse XFe Mitochondrial Analyzer monitors oxygen consumption in the analyzed cells to 
assess levels of oxidative phosphorylation taking place, and monitors lactate production as an 
indicator for levels of glycolysis. Cells are grown in specially designed 24 well plates which are 
loaded into the Seahorse analyzer. 
I was able to perform three Seahorse analysis of HFFs infected with T. gondii. The 
Seahorse 24 well plates were seeded with HFFs a week before the analysis, allowing suitable time 
for them to become confluent. A day before the analysis, they were infected with T. gondii. After 
3 experiments with extremely variable results, I discovered that the viability of the HFFs in outer 
wells of the plates was compromised due to evaporation of growth medium. This was likely the 
reason for the inconsistent results. If additional Seahorse experiments are performed, special care 
should be made to ensure no growth medium evaporates while the HFFs are allowed to grow to 
confluence. Before infecting any of the cells with T. gondii, it is imperative that each well is 
examined to confirm the health of the cells. If any of the infected cells are not healthy and 
confluent, the results will not be consistent. 
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APPENDIX C CLICK REACTION 
Below is a detailed protocol for performing the copper(I)-catalyzed “click” cycloaddition reaction. 
Stock solutions needed: 
TCEP (tris(2-carboxyethyl)phosphine), Sigma-Aldrich, Prod. No. C4706 
- prepare 50x stock in distilled water, make fresh for each experiment 
o to make 1 ml of 50x stock: 14.3 mg in 1 ml of distilled water 
 
TBTA (tris-(benzyltriazolylmethyl)amine ligand), Sigma-Aldrich, Prod. No. 678937 
- prepare 17x solution in DMSO and t-Butanol (1:4) 
o to make 17x stock: 0.045 g in 10 ml DMSO and 40 ml t-Butanol 
 
CuSO4 (copper (II) sulfate), Sigma-Aldrich, Prod. No. C1297 
- prepare 50x solution in distilled water 
o to make 50x stock: 0.339 g in 50 ml distilled water 
Biotin-alkyne (PEG4 carboxamide-propargyl biotin), Invitrogen, Cat. No. B10185 
- prepare 4 mM solution in DMSO 
 
Setting up a 50 µl reactions: 
Reaction Component Final Conc. Vol. of stock 
TCEP (50x) 1 mM 1.0 µl 
TBTA (17x) 100 µM 2.9 µl 
CuSO4 (50x) 1 mM 1.0 µl 
Biotin-alkyne (4 mM) 50 µM 0.6 µl 
Azide labeled sample - 45 µl 
 
1. Combine reaction components in a 1.5 ml eppendorf tube and gently vortex. 
2. Allow samples to incubate at room temperature for at 1 hour with rotation. 
3. After the incubation is completed, the click reaction is finished. There is nothing done to 
stop the reaction. For temporary storage, the samples stored in the -20oC freezer, or -80oC 
freezer for long term storage. 
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APPENDIX D ANL-LABELING EXPERIMENT, NEUTRAVIDIN PURIFICATION 
 
Below is a detailed protocol for performing an Anl-labeling experiment, followed by a neutravidin 
purification. 
 
Strains utilized: 
1.  WT T. gondii (Me49∆Hpt:Luc + MetRS clone 2) 
2.  Tg-MetRSNLL strain (Me49∆Hpt:Luc + MetRS clone 12) 
 
I. Grow parasites in the presence of azidonorleucine (Anl) for 48 hours in human foreskin 
fibroblasts (HFFs) 
 
1. Obtain a T25 culture flask of HFFs and check for the confluence of the cells under the 
microscope. Remove the media and replace it with 4ml of cDMEM. Note: Depending on 
how many parasites you want to collect in the end, you may need to infect multiple T25s 
per strain and combine them isolating the parasites during step 6-7. 
2. Infect the HFFs with parasites at the multiplicity of infection (MOI) of 3. 
a. Add 1 mM Anl to the T25 culture flask (from a 100 mM stock solution, stored at -
80oC). 
3. Allow parasites to grow for 48 hours in a 37oC incubator with CO2. 
4. After 48 hours of grow, check to confirm that the HFFs are well infected. 
5. Wash the infected HFFs with 3ml of PBS. 2x. 
6. Scrape off the HFF monolayer from the T25 culture flask in 3ml of PBS with protease 
inhibitors (cOmplete EDTA-free protease inhibitors, prepare a 50x stock). Lyse infected 
HFFs by passage through a 25g and 27g needle. Count parasites. 
7. Transfer solution to a 15 ml centrifuge tube and centrifuge at 800xg for 10 minutes. 
8. Aspirate off the supernatant and resuspend the pelleted parasites in 100 µl of 2% SDS in 
PBS. At this point, the sample can be transferred into a 1.5 ml Eppendorf tube. 
9. Transfer the samples to a 95oC heat block for 5 minutes to help solubilize the parasites. 
Note: Condensation can build up and cause the lids to pop open during this step. 
10. Dilute the samples to 0.5% SDS with PBS with protease inhibitors (292ul of PBS + 8ul 
of 50x protease inhibitor stock). You should now have 400 µl of each sample, ready for 
click chemistry. 
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II. Click reaction 
For a detailed explanation of preparing the stock solutions for the reaction, see Appendix C. 
 
Performing a 50 ul reaction (1x) is standard, where 45 µl of your azide-labeled sample is utilized. 
In this case, we have 400ul of sample. If we want to use all for the click reaction: 45/400 = 8.9 
Reaction Component Final Conc. 
Vol.of stock 
(1x) 
Vol. of stock 
(8.9x) 
TCEP (50x) 1 mM 1.0 µl 8.9 µl 
TBTA (17x) 100 µM 2.94 µl 26.17 µl 
CuSO4 (50x) 1 mM 1.0 µl 8.9 µl 
Biotin-alkyne  (4 mM) 50 µM 0.6 µl 5.34 µl 
Azide-labeled sample - 45 µl 400 µl 
 
1. Combine reaction components in a 1.5 ml eppendorf tube and gently vortex. 
2. Allow samples to incubate at room temperature for 1 hour with rotation. 
3. Samples are now ready for neutravidin purification. There is nothing done to stop the 
reaction. 
III. Neutravidin Purification 
200 µl of each sample will be used from the purification, and the other 200 µl saved as the input. 
 
Equilibrate the neutravidin resin: 
1. Obtain 200ul of well mixed neutravidin resin per sample. 
2. Centrifuge at 2500xg for 1 minute. Remove and discard the supernatant. 
3. Equilibrate the resin by adding 500 µl of 0.5% SDS in PBS. Centrifuge at 2500xg for 1 
minute. Remove and discard the supernatant. Repeat 2x. 
Incubation with the neutravidin resin: 
1. Add 200 µl of sample to the resin (leaving the other 200 µl for the input) 
2. Put the samples on a rotator at room temperature for 2 hours. 
3. After incubation, centrifuge the samples at 2500xg for 1 minute. Remove and save the 
supernatant as an “unbound” sample. 
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4. Wash the resin by adding 1 ml of PBS. Centrifuge at 2500xg for 1 minute. Remove and 
discard the supernatant. Repeat 2x. 
5. Add 1 ml of 0.2% SDS in PBS. Centrifuge at 2500xg for 1 minute. Remove and discard 
the supernatant. 
6. Wash 1 final time with 1ml of PBS. Centrifuge at 2500xg for 1 minute. Remove and discard 
the supernatant. 
 
Elution of bound sample: 
1. Elute sample from the resin by adding 200 µl of 1x SDS dye. Boil for 5 minutes on a heat 
block at 95oC. 
2. Centrifuge at 2500xg for 1 minute. Collect the supernatant as the elution (200 µl). 
3. Repeat the above 2 steps for a second elution sample. 
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